Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 19 of 110 Updated Nov 17, 2026

LL-37

Cathelicidin · hCAP-18 C-terminus

PRECLINICAL + ANIMAL STUDIES · CATHELICIDIN ANTIMICROBIAL PEPTIDE; HOST-DEFENSE

▓ 239 indexed citations across PubMed (191), EuropePMC (48).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

239 citations across 7 tiers

Tap any tier to jump to that section of the bibliography.

Background

Cathelicidin antimicrobial peptide (CAMP) is an antimicrobial peptide encoded in the human by the CAMP gene. The active form is LL-37, a 37 amino acid peptide having sequence LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES. In humans, CAMP encodes the peptide precursor CAP-18, which is processed by proteinase 3-mediated extracellular cleavage into the active form LL-37.

→ Wikipedia

Mechanism of action

Cationic amphipathic α-helix disrupts microbial membranes; modulates host immune response

Researched effects

Broad-spectrum antimicrobial; wound healing; biofilm disruption; immune modulation

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

100-500 mcg SC daily (research)

Known concerns

Pro-inflammatory at high doses (rosacea link); cytotoxicity at high concentrations

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. Salivary antimicrobial peptides histatin-5, beta defensins, human neutrophilic peptides, LL-37, and calprotectin in severe dental caries, with a focus on early childhood caries: a systematic review and meta-analysis.

    Odontology · 2026 — META-ANALYSES · AUTHORITY 94.5

  2. Cathelicidin antimicrobial peptides: current progress and future prospects in immunotherapy.

    Developmental and comparative immunology · 2026 — SYSTEMATIC REVIEWS · AUTHORITY 84.5

  3. Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.

    Journal of biological regulators and homeostatic agents · 2017 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 73.7

  4. Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.

    Clinical and investigative medicine. Medecine clinique et experimentale · 2017 — CLINICAL TRIALS · AUTHORITY 68.7

  5. Human cathelicidin antimicrobial protein 18 (hCAP18/LL-37) is increased in foetal membranes and myometrium after spontaneous labour and delivery.

    Journal of reproductive immunology · 2015 — CLINICAL TRIALS · AUTHORITY 68.5

  6. Cancer cell migration under control of human cathelicidin LL-37.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026 — REVIEWS · AUTHORITY 54.5

  7. LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease.

    Immunity, inflammation and disease · 2026 — REVIEWS · AUTHORITY 54.5

  8. Linking skin to system: LL-37 as a potential molecular link between psoriasis and its comorbidities.

    Autoimmunity reviews · 2026 — REVIEWS · AUTHORITY 54.5

  9. LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies.

    Clinical, cosmetic and investigational dermatology · 2026 — REVIEWS · AUTHORITY 54.5

  10. LL-37-based oral antimicrobial therapeutics: translational challenges and future directions-a narrative review.

    Odontology · 2026 — REVIEWS · AUTHORITY 54.5

Full citation library

Year distribution

Meta-Analyses

1
  1. 1.

    Muruganandhan J, Veeraraghavan VP, Sujatha G, Subramani S, et al. · Odontology · 2026 · PMID 42295538

    This systematic review and meta-analysis was performed to collect evidence on the association between salivary antimicrobial peptides (AMPs) and severe dental caries, with a focus on Early Childhood caries (ECC). Findings regarding AMPs can assess their potential as biomarkers for disease susceptibility and progression. A comprehensive search of PubMed, Scopus, and ClinicalKey was conducted up to 2025. Studies reporting salivary AMP concentrations in caries-affected and caries-free individuals w…

Systematic Reviews

1
  1. 2.

    Ding A, Lu Z, Wu J, Chen Z, et al. · Developmental and comparative immunology · 2026 · PMID 42229867

    Antimicrobial peptides (AMPs) are small molecules with defensive effects that are crucial in innate immune defense. Cathelicidin AMPs are a major AMP family found in humans and other vertebrates, originating from various cell types such as neutrophils, macrophages, pancreatic β-cells and epithelial cells. Cathelicidin AMPs serve as a vital line of defense for the immune system. With the rise of antibiotic resistance, many studies are paying attention to cathelicidin AMPs, classic distinctive sma…

Randomised Controlled Trials

1
  1. 3.

    Majewski K, Agier J, Kozłowska E, Brzezińska-Błaszczyk E · Journal of biological regulators and homeostatic agents · 2017 · PMID 28956425

    A growing body of evidence indicates the role of cathelicidin LL-37, a member of the antimicrobial peptide family, in host innate defense mechanisms. The important role of this peptide in infectious diseases is also suggested, however, to date, data relating to LL-37 expression in the course of bacterial infections are far from complete. Therefore, the aim of the present study was to determine LL-37 serum levels in adult patients with pulmonary tuberculosis (TB). For comparison, circulating LL-3…

Clinical Trials

2
  1. 4.

    Lim R, Barker G, Lappas M · Journal of reproductive immunology · 2015 · PMID 25435436

    Infection and/or inflammation are most commonly associated with preterm birth. Studies have shown that antimicrobial peptides can modulate the inflammatory response in non-gestational tissues; the human cathelicidin hCAP18 (and its active component LL-37) has such anti-microbial and immunomodulatory properties. The aim of this study was to determine the effect of human labour on hCAP18 expression in foetal membranes and myometrium, and to determine the effect of the synthetic LL-37 peptide on pr…

  2. 5.

    Majewski K, Żelechowska P, Brzezińska-Błaszczyk E · Clinical and investigative medicine. Medecine clinique et experimentale · 2017 · PMID 28218580

    The antimicrobial peptide cathelicidin LL-37 plays a role in the immune response in the course of lung infections; however, the exact role of LL-37 in defense mechanisms against bacteria within the respiratory tract is has not been precisely described. The aim of our study was to evaluate LL-37 concentrations in the serum of pulmonary tuberculosis (TB) patients, patients with pneumonia caused by Gram-positive and Gram-negative bacteria and to compare them with those of healthy subjects. Thirty T…

Reviews

60
  1. 6.

    Memariani H, Memariani M · World journal of microbiology & biotechnology · 2023 · PMID 36781570

    Notwithstanding ceaseless endeavors toward developing effective antibiofilm chemotherapeutics, biofilm-associated infections continue to be one of the most perplexing challenges confronting medicine today. Endogenous host defense peptides, such as the human cathelicidin LL-37, are being propounded as promising options for treating such infectious diseases. Over the past decennium, LL-37 has duly received tremendous research attention by virtue of its broad-spectrum antimicrobial activity and imm…

  2. 7.

    Leite ML, Duque HM, Rodrigues GR, da Cunha NB, et al. · Peptides · 2023 · PMID 37068711

    Host defense peptides (HDPs) are naturally occurring polypeptide sequences that, in addition to being active against bacteria, fungi, viruses, and other parasites, may stimulate immunomodulatory responses. Cathelicidins, a family of HDPs, are produced by diverse animal species, such as mammals, fish, birds, amphibians, and reptiles, to protect them against pathogen infections. These peptides have variable C-terminal domains responsible for their antimicrobial and immunomodulatory activities and…

  3. 8.

    Takahashi T, Yamasaki K · International journal of molecular sciences · 2020 · PMID 32947991

    Psoriasis is a systemic inflammatory disease caused by crosstalk between various cells such as T cells, neutrophils, dendritic cells, and keratinocytes. Antimicrobial peptides (AMPs) such as β-defensin, S100, and cathelicidin are secreted from these cells and activate the innate immune system through various mechanisms to induce inflammation, thus participating in the pathogenesis of psoriasis. In particular, these antimicrobial peptides enhance the binding of damage-associated molecular pattern…

  4. 9.

    Fahy RJ, Wewers MD · Immunologic research · 2005 · PMID 15778507

    Antimicrobial peptides form an important component of the innate immune system. The cathelicidin family, a key member of the antimicrobial peptide defenses, has been highly conserved throughout evolution. Though widespread in mammals, there is currently only one identified human example, hCAP-18/LL-37. The cathelicidins have been found to have multiple functions, in addition to their known antimicrobial and lipopolysaccharide-neutralizing effects. As a result, they profoundly affect both innate…

  5. 10.

    Tokajuk J, Deptuła P, Piktel E, Daniluk T, et al. · Biomedicines · 2022 · PMID 35625823

    The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various imm…

  6. 11.

    Fabisiak A, Murawska N, Fichna J · Pharmacological reports : PR · 2016 · PMID 27117377

    Antimicrobial peptides (AMPs) is a large family of compounds serving as natural antibiotics, widely distributed across the organism, mainly in mucus layers. They are designed to prevent pathogens from colonization. Among them, defensins and cathelicidins could be found. LL-37, the sole human cathelicidin draws particular attention because of its outstanding abilities. In addition to being a broad spectrum antibiotic, LL-37 has potent chemotactic and immunomodulatory properties. In this review, w…

  7. 12.

    Bandurska K, Berdowska A, Barczyńska-Felusiak R, Krupa P · BioFactors (Oxford, England) · 2015 · PMID 26434733

    Cathelicidins are antimicrobial peptides produced by humans and animals in response to various pathogenic microbes. This review intends to provide a brief overview of the expression, structure, properties and function of human cathelicidin LL-37 which may be a therapeutic agent against a variety of bacterial and viral diseases, cancers, and hard-to-heal wounds. Cathelicidins act as a primary defense against bacteria and other pathogens in the case of inflammation. They are able to kill bacteria…

  8. 13.

    Chen X, Zou X, Qi G, Tang Y, et al. · Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2018 · PMID 29843147

    LL-37, the C-terminal peptide of human cathelicidin antimicrobial peptide (CAMP, hCAP18), reportedly increases resistance to microbial invasion and exerts important physiological functions in chemotaxis, promotion of wound closure, and angiogenesis. Accumulating evidence indicates that LL-37 also plays a significant role in human cancer. LL-37 induces tumorigenic effects in cancers of the ovary, lung, breast, prostate, pancreas, as well as in malignant melanoma and skin squamous cell carcinoma.…

  9. 14.

    Piktel E, Niemirowicz K, Wnorowska U, Wątek M, et al. · Archivum immunologiae et therapiae experimentalis · 2016 · PMID 26395996

    LL-37 is a C-terminal peptide proteolytically released from 18 kDa human cathelicidin protein (hCAP18). Chronic infections, inflammation, tissue injury and tissue regeneration are all linked with neoplastic growth, and involve LL-37 antibacterial and immunomodulatory functions. Such a link points to the possible involvement of LL-37 peptide in carcinogenesis. An increasing amount of evidence suggests that LL-37 can have two different and contradictory effects--promotion or inhibition of tumor gr…

  10. 15.

    Bucki R, Leszczyńska K, Namiot A, Sokołowski W · Archivum immunologiae et therapiae experimentalis · 2010 · PMID 20049649

    The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of bacterial wall molecules such as lipopolysaccharide and can therefore protect against lethal endotoxemia. Additional reported activities of LL-37…

  11. 16.

    Memariani M, Memariani H · World journal of microbiology & biotechnology · 2023 · PMID 38057654

    The threat of fungal diseases is substantially underestimated worldwide, but they have serious consequences for humans, animals, and plants. Given the limited number of existing antifungal drugs together with the emergence of drug-resistant strains, many researchers have actively sought alternatives or adjuvants to antimycotics. The best way to tackle these issues is to unearth potential antifungal agents with new modes of action. Antimicrobial peptides are being hailed as a promising source of…

  12. 17.

    Sun L, Wang W, Xiao W, Yang H · Inflammatory bowel diseases · 2016 · PMID 27135484

    Human cathelicidin LL-37, the only member of the cathelicidin family of host defense peptides expressed in humans, plays a crucial role in host defense against pathogen invasion, as well as in regulating the functions of anti-inflammation, antitumorigenesis, and tissue repair. It is primarily produced by phagocytic leukocytes and epithelial cells, and mediates a wide range of biological responses. Emerging evidence from several studies indicates that LL-37 plays a prominent and complex role in i…

  13. 18.

    Miao S, Liu H, Yang Q, Zhang Y, et al. · Pharmacological research · 2024 · PMID 39615616

    Heart disease is a common human disease with high morbidity and mortality. Timely and effective prevention and treatment is an urgent clinical problem. The pathogenesis of heart disease is complex and diverse, involving hypertension, diabetes, atherosclerosis, drug toxicity, thrombosis, infection and other aspects. LL-37, an endogenous peptide, is well known for its antimicrobial properties. In recent years, LL-37 has been found to have a variety of biological functions, including its role in th…

  14. 19.

    Moreno-Angarita A, Aragón CC, Tobón GJ · Journal of translational autoimmunity · 2020 · PMID 32743514

    Cathelicidin LL-37 is an antimicrobial peptide that is synthesized by epithelial cells, neutrophils, or lymphocytes and act as an essential defense mechanism against bacterial, viral, or fungi infection of eukaryotic organisms. However, in recent years, this cathelicidin has gained the interest of the scientific community because, besides its antimicrobial properties, LL-37 is an immunomodulator that can contribute to the development of autoimmune diseases. The other non-antimicrobial function o…

  15. 20.

    Xhindoli D, Pacor S, Benincasa M, Scocchi M, et al. · Biochimica et biophysica acta · 2016 · PMID 26556394

    The human cathelicidin hCAP18/LL-37 has become a paradigm for the pleiotropic roles of peptides in host defence. It has a remarkably wide functional repertoire that includes direct antimicrobial activities against various types of microorganisms, the role of 'alarmin' that helps to orchestrate the immune response to infection, the capacity to locally modulate inflammation both enhancing it to aid in combating infection and limiting it to prevent damage to infected tissues, the promotion of angio…

  16. 21.

    Voronko OE, Khotina VA, Kashirskikh DA, Lee AA, et al. · International journal of molecular sciences · 2025 · PMID 40869425

    Cathelicidins are a family of antimicrobial peptides (AMPs) with broad-spectrum activity and immunomodulatory functions. Among them, the only human cathelicidin LL-37 has garnered significant interest due to its potent antimicrobial, antiviral, antifungal, antiparasitic, and antitumor properties. However, the clinical application of LL-37 is hindered by several limitations, including low proteolytic stability, cytotoxicity, and high production costs. To overcome these challenges, a wide range of…

  17. 22.

    Nagaoka I, Tamura H, Reich J · International journal of molecular sciences · 2020 · PMID 32825174

    Among the mechanisms put-up by the host to defend against invading microorganisms, antimicrobial peptides represent the first line. In different species of mammals, the cathelicidin family of antimicrobial peptides AMPs has been identified, and in humans, LL-37 is the only type of cathelicidin identified. LL-37 has many different biological activities, such as regulation of responses to inflammation, besides its lipopolysaccharide (LPS)-neutralizing and antimicrobial and activities. Recently, em…

  18. 23.

    Wang G, Narayana JL, Mishra B, Zhang Y, et al. · Advances in experimental medicine and biology · 2019 · PMID 30980360

    The incorporation of the innate immune system into humans is essential for survival and health due to the rapid replication of invading microbes and the delayed action of the adaptive immune system. Antimicrobial peptides are important components of human innate immunity. Over 100 such peptides have been identified in various human tissues. Human cathelicidin LL-37 is best studied, and there has been a growing interest in designing new peptides based on LL-37. This chapter describes the alternat…

  19. 24.

    Zielke C, Nielsen JE, Lin JS, Barron AE · Biophysical journal · 2024 · PMID 37919905

    The innate immune system provides a crucial first line of defense against invading pathogens attacking the body. As the only member of the human cathelicidin family, the antimicrobial peptide LL-37 has been shown to have antiviral, antifungal, and antibacterial properties. In complexation with nucleic acids, LL-37 is suggested to maintain its beneficial health effects while also acting as a condensation agent for the nucleic acid. Complexes formed by LL-37 and nucleic acids have been shown to be…

  20. 25.

    Chieosilapatham P, Ikeda S, Ogawa H, Niyonsaba F · Current pharmaceutical design · 2018 · PMID 29589544

    Cathelicidins form one of the major families of antimicrobial peptides and have been identified in many vertebrates, including humans. LL-37, the only human member of the cathelicidin family, is detected in most sites of the human body that is normally exposed to microbes, including the epithelial lining of the skin, gastrointestinal tract, genitourinary tract and lungs. This peptide is also expressed by a variety of epithelial cells and immune cells, such as neutrophils, monocytes and mast cell…

  21. 26.

    Kuroda K, Okumura K, Isogai H, Isogai E · Frontiers in oncology · 2015 · PMID 26175965

    Antimicrobial peptides (AMPs) play a critical role in innate host defense against microbial pathogens in many organisms. The human cathelicidin, LL-37, has a net positive charge and is amphiphilic, and can eliminate pathogenic microbes directly via electrostatic attraction toward negatively charged bacterial membranes. A number of studies have shown that LL-37 participates in various host immune systems, such as inflammatory responses and tissue repair, in addition to its antibacterial propertie…

  22. 27.

    Verjans ET, Zels S, Luyten W, Landuyt B, et al. · Peptides · 2016 · PMID 27609777

    The human cathelicidin peptide LL-37 plays a crucial role in the immune system on many levels, from the first line of defense in epithelial cells to restoring the tissue after infection. On host cells, the majority of the LL-37-induced effects are mediated via the direct or indirect activation of several structurally unrelated cell surface receptors or intracellular targets. How LL-37 is able to affect multiple receptors is currently not well understood. So far, the mechanistic details underlyin…

  23. 28.

    Nijnik A, Hancock RE · Current opinion in hematology · 2009 · PMID 19068548

    LL-37 is the only member of the cathelicidin family of host defence peptides expressed in humans. It is primarily produced by phagocytic leucocytes and epithelial cells, and mediates a wide range of biological responses: direct killing of microorganisms, chemotaxis and chemokine induction, regulation of inflammatory responses, as well as adjuvant, angiogenic and wound healing effects. In this review we will cover the recent advances in the understanding of LL-37 biology: its activities, the mech…

  24. 29.

    Aloul KM, Nielsen JE, Defensor EB, Lin JS, et al. · Frontiers in immunology · 2022 · PMID 35634307

    COVID-19 is characterized by hyperactivation by inflammatory cytokines and recruitment of macrophages, neutrophils, and other immune cells, all hallmarks of a strong inflammatory response that can lead to severe complications and multi-organ damage. Mortality in COVID-19 patients is associated with a high prevalence of neutrophil extracellular trap (NET) formation and microthrombosis that are exacerbated by hyperglycemia, diabetes, and old age. SARS-CoV-2 infection in humans and non-human primat…

  25. 30.

    He Y, Zhou Y, Liu N, Zhang W, et al. · International immunopharmacology · 2025 · PMID 39954662

    LL-37 is the sole member of the cathelicidin family of antimicrobial peptides in humans, primarily produced by phagocytic leukocytes and epithelial cells, mediating a wide range of biological responses. Discovered in human neutrophils, LL-37 is known for its broad-spectrum antimicrobial activity and immunomodulatory functions. In periodontitis, LL-37 is mainly expressed in gingival epithelium, gingival sulcus fluid, and saliva. Emerging evidence from several studies suggests that LL-37 is signif…

  26. 31.

    Popa AD, Gherasim A, Caba L, Niță O, et al. · Metabolites · 2024 · PMID 39728453

  27. 32.

    Silva-Carvalho AÉ, Cardoso MH, Alencar-Silva T, Bogéa GMR, et al. · Pharmacology & therapeutics · 2022 · PMID 34637839

    Among the various biological properties presented by Mesenchymal Stem Cells (MSCs), their ability to control the immune response and fight pathogen infection through the production of antimicrobial peptides (AMPs) have been the subject of intense research in recent years. AMPs secreted by MSCs exhibit activity against a wide range of microorganisms, including bacteria, fungi, yeasts, and viruses. The main AMPs produced by these cells are hepcidin, cathelicidin LL-37, and β-defensin-2. In additio…

  28. 33.

    Méndez-Samperio P · Peptides · 2010 · PMID 20600427

    Antimicrobial peptides are predominantly small cationic polypeptides that are classified together on the basis of these molecules to directly kill or inhibit the growth of microorganisms including mycobacteria, and to activate mechanisms of cellular and adaptive immunity. Various families of antimicrobial peptides have been identified, including the cathelicidins. The cathelicidin family is characterised by a conserved N-terminal cathelin domain and a variable C-terminal antimicrobial domain tha…

  29. 34.

    Tjabringa GS, Rabe KF, Hiemstra PS · Pulmonary pharmacology & therapeutics · 2005 · PMID 15939310

    Antimicrobial peptides play an important role in innate immunity of the lung by acting as effector molecules in host defence against inhaled pathogens. Various families of antimicrobial peptides have been identified, including the cathelicidins. Cathelicidins are characterized by a conserved N-terminal cathelin domain and a variable C-terminal antimicrobial domain that can be released from the precursor protein after cleavage by proteinases. LL-37 is the C-terminal part of the only human catheli…

  30. 35.

    Zhang Q, Ul Ain Q, Schulz C, Pircher J · Frontiers in immunology · 2023 · PMID 37090695

    Thrombosis is a frequent cause of cardiovascular mortality and hospitalization. Current antithrombotic strategies, however, target both thrombosis and physiological hemostasis and thereby increase bleeding risk. In recent years the pathophysiological understanding of thrombus formation has significantly advanced and inflammation has become a crucial element. Neutrophils as most frequent immune cells in the blood and their released mediators play a key role herein. Neutrophil-derived cathelicidin…

  31. 36.

    Galdo-Torres D, Andreu S, Caballero O, Hernández-Ruiz I, et al. · International journal of molecular sciences · 2025 · PMID 40004230

    In addition to its classical role in calcium and phosphate metabolism regulation, vitamin D also has an important impact on immunity modulation. Vitamin D regulates the immune response, shifting from a proinflammatory state to a more tolerogenic one by increasing the release of anti-inflammatory cytokines while downregulating proinflammatory cytokines. Thus, low levels of vitamin D have been associated with an increased risk of developing autoimmune diseases like multiple sclerosis and type 1 di…

  32. 37.

    Zeth K, Sancho-Vaello E · International journal of molecular sciences · 2021 · PMID 34068993

    The human cathelicidin LL-37 is a multifunctional peptide of the human innate immune system. Among the various functions of LL-37, its antimicrobial activity is important in controlling the microorganisms of the human body. The target molecules of LL-37 in bacteria include membrane lipids, lipopolysaccharides (LPS), lipoteichoic acid (LTA), proteins, DNA and RNA. In this mini-review, we summarize the entity of LL-37 structural data determined over the last 15 years and specifically discuss featu…

  33. 38.

    Yang B, Good D, Mosaiab T, Liu W, et al. · BioMed research international · 2020 · PMID 32509872

    LL-37, also called cathelicidin, is an important part of the human immune system, which can resist various pathogens. A plethora of experiments have demonstrated that it has the multifunctional effects of immune regulation, in addition to antimicrobial activity. Recently, there have been increasing interest in its immune function. It was found that LL-37 can have two distinct functions in different tissues and different microenvironments. Thus, it is necessary to investigate LL-37 immune functio…

  34. 39.

    Svensson D, Nilsson BO · Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025 · PMID 40063262

    Human cathelicidin LL-37 shows activity towards both gram-positive and gram-negative bacteria, and it is also active against some types of viruses. Besides its antimicrobial effects, the peptide modulates innate immunity through binding and inactivation of bacterial endotoxins and promoting chemotaxis of immune cells. LL-37 is reported to interact with plasma membrane receptors and mediate import of Ca Altogether, LL-37 may inhibit and prevent the infection from spreading by direct anti-bacteria…

  35. 40.

    Iacob SA, Iacob DG · Protein and peptide letters · 2014 · PMID 25101632

    The human cathelicidin-18 is an antimicrobial, immunomodulatory and tissue repair peptide. The LL-37 fragment of this peptide which is in fact the active domain of the cathelicidin-18 is critical for the human antibacterial defense and epithelial integrity. It's activity against resistant pathogens, the potential of epithelial healing after microbial injury and the neutralization of bacterial endotoxin underlie the most important benefits of this peptide. However, there are still a number of que…

  36. 41.

    Neshani A, Zare H, Ghiasi NS, Karimi MA, et al. · Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2025 · PMID 41270816

    The emergence of antibiotic-resistant pathogens is a significant global health concern that necessitates the development of new antimicrobial drugs. Due to its broad-spectrum action against bacteria, fungi, and viruses, human cathelicidin LL-37, an antimicrobial peptide (AMP), has emerged as a potential option. Data from PubMed, Scopus, Google Scholar, and Web of Science up to March 30, 2025, were investigated in this study. Studies were considered depending on their analysis of LL-37's structur…

  37. 42.

    Wnorowska U, Fiedoruk K, Piktel E, Prasad SV, et al. · Journal of nanobiotechnology · 2020 · PMID 31898542

    Nanotechnology-based therapeutic approaches have attracted attention of scientists, in particular due to the special features of nanomaterials, such as adequate biocompatibility, ability to improve therapeutic efficiency of incorporated drugs and to limit their adverse effects. Among a variety of reported nanomaterials for biomedical applications, metal and metal oxide-based nanoparticles offer unique physicochemical properties allowing their use in combination with conventional antimicrobials a…

  38. 43.

    Tanphaichitr N, Srakaew N, Alonzi R, Kiattiburut W, et al. · Pharmaceuticals (Basel, Switzerland) · 2016 · PMID 26978373

    The concurrent increases in global population and sexually transmitted infection (STI) demand a search for agents with dual spermicidal and microbicidal properties for topical vaginal application. Previous attempts to develop the surfactant spermicide, nonoxynol-9 (N-9), into a vaginal microbicide were unsuccessful largely due to its inefficiency to kill microbes. Furthermore, N-9 causes damage to the vaginal epithelium, thus accelerating microbes to enter the women's body. For this reason, anti…

  39. 44.

    Bals R, Wilson JM · Cellular and molecular life sciences : CMLS · 2003 · PMID 12785718

    One component of host defence at mucosal surfaces are epithelial-derived antimicrobial peptides. Cathelicidins are one family of antimicrobial peptides characterized by conserved pro-peptide sequences that have been identified in several mammalian species. LL-37/hCAP-18 is the only cathelicidin found in humans and is expressed in inflammatory and epithelial cells. Besides their direct antimicrobial function, cathelicidins have multiple roles as mediators of inflammation influencing diverse proce…

  40. 45.

    Jacobsen AS, Jenssen H · Future medicinal chemistry · 2012 · PMID 22917247

    Human pathogens often colonize their host by the formation of biofilms. These surface-attached aggregates of bacteria are characterized by a self-produced extracellular matrix, which makes them highly resistant towards antibiotic treatment. Their abilities to adhere to abiotic surfaces (e.g., catheters and other medical devices) also makes bacterial biofilm formation a challenge in modern medicine. Antimicrobial peptides have lately been introduced as a potential class of drug molecules for comb…

  41. 46.

    van der Does AM, Bergman P, Agerberth B, Lindbom L · Journal of leukocyte biology · 2012 · PMID 22701042

    As traditional antibiotics gradually become inefficient, there is a high demand for development of anti-infectives with a mechanism of action that is different from existing antibiotics. Current antibiotics target the pathogen directly, thereby contributing to the selection of multidrug-resistant bacterial strains. AMPs, such as the human cathelicidin LL-37, are small cationic peptides that are part of host defense. They eliminate microbes through diverse mechanisms, thereby contributing to reso…

  42. 47.

    Żochowski K, Sadowska M, Piktel E, Pogoda K, et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026 · PMID 41916132

    Cancer cell migration is a key step in the metastatic cascade. Understanding its mechanisms represents one of the greatest challenges in modern oncology. Both in vitro and in vivo experimental models and mathematical descriptions of movement dynamics are used to study this complex phenomenon. These models allow for the quantitative characterization of movement trajectories based on cell motion parameters. Within the tumor microenvironment, the human cathelicidin LL-37 holds a special place as a…

  43. 48.

    Pahar B, Madonna S, Das A, Albanesi C, et al. · Vaccines · 2020 · PMID 32927756

    Antimicrobial peptides (AMPs) are produced by neutrophils, monocytes, and macrophages, as well as epithelial cells, and are an essential component of innate immunity system against infection, including several viral infections. AMPs, in particular the cathelicidin LL-37, also exert numerous immunomodulatory activities by inducing cytokine production and attracting and regulating the activity of immune cells. AMPs are scarcely expressed in normal skin, but their expression increases when skin is…

  44. 49.

    Wang G, Mishra B, Epand RF, Epand RM · Biochimica et biophysica acta · 2014 · PMID 24463069

    Host defense antimicrobial peptides are key components of human innate immunity that plays an indispensible role in human health. While there are multiple copies of cathelicidin genes in horses, cattle, pigs, and sheep, only one cathelicidin gene is found in humans. Interestingly, this single cathelicidin gene can be processed into different forms of antimicrobial peptides. LL-37, the most commonly studied form, is not only antimicrobial but also possesses other functional roles such as chemotax…

  45. 50.

    Dürr UH, Sudheendra US, Ramamoorthy A · Biochimica et biophysica acta · 2006 · PMID 16716248

    Antimicrobial peptides and their precursor molecules form a central part of human and mammalian innate immunity. The underlying genes have been thoroughly investigated and compared for a considerable number of species, allowing for phylogenetic characterization. On the phenotypical side, an ever-increasing number of very varied and distinctive influences of antimicrobial peptides on the innate immune system are reported. The basic biophysical understanding of mammalian antimicrobial peptides, ho…

  46. 51.

    Doss M, White MR, Tecle T, Hartshorn KL · Journal of leukocyte biology · 2010 · PMID 19808939

    Defensins are widespread in nature and have activity against a broad range of pathogens. Defensins have direct antimicrobial effects and also modulate innate and adaptive immune responses. We consider the role of human defensins and the cathelicidin LL-37 in defense of respiratory, gastrointestinal, and genitourinary tracts and the oral cavity, skin, and eye. Human beta-defensins (hBDs) and human defensins 5 and 6 (HD5 and -6) are involved most obviously in mucosal responses, as they are produce…

  47. 52.

    Schauber J, Ruzicka T, Rupec RA · Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2008 · PMID 18209993

    Keratinocytes produce and secrete antimicrobial peptides which function as endogenous antibiotics and as signaling molecules within the cutaneous innate immune system. Recent studies demonstrate that the antimicrobial peptide cathelicidin LL-37 plays an important role in the pathogenesis of atopic eczema, rosacea and psoriasis. Whereas skin in atopic eczema shows decreased cathelicidin expression which leads to increased susceptibility to superinfection in those patients, overabundant expression…

  48. 53.

    Lehrer RI, Ganz T · Current opinion in hematology · 2002 · PMID 11753073

    The cytoplasmic granules of mammalian neutrophils contain several antimicrobial peptides. Some, like defensins, are fully processed before storage, whereas others are stored as precursors that require additional processing. Cathelicidins are bipartite molecules with an N-terminal cathelin domain and an antimicrobial C-terminal domain. Humans apparently have only one cathelicidin gene. Its product, hCAP-18, is present in the secondary (specific) granules of neutrophils, and its C-terminal antimic…

  49. 54.

    Vandamme D, Landuyt B, Luyten W, Schoofs L · Cellular immunology · 2012 · PMID 23246832

    Cathelicidins are a group of antimicrobial peptides. Since their discovery, it has become clear that they are an exceptional class of peptides, with some members having pleiotropic effects. Not only do they possess an antibacterial, antifungal and antiviral function, they also show a chemotactic and immunostimulatory/-modulatory effect. Moreover, they are capable of inducing wound healing, angiogenesis and modulating apoptosis. Recent insights even indicate for a role of these peptides in cancer…

  50. 55.

    Lou J, He X · Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control · 2024 · PMID 38604693

    Parasitic diseases caused by protozoan and helminth infections are still widespread across the world, notably in tropical and subtropical areas, which threaten the children and adult health. Long-term use of anti-parasitic drugs may result in reduced drug susceptibility and even drug resistance. Antimicrobial peptides have been demonstrated to inhibit parasite growth and development, which has potential antiparasitic values. LL-37, the only human antimicrobial peptide in the cathelicidin family,…

  51. 56.

    Mańkowska A, Paprocka P, Król G, Lesiak A, et al. · Archivum immunologiae et therapiae experimentalis · 2025 · PMID 40960088

    Antimicrobial peptides, which function as the first line of host immune defense, have recently been identified as important immunomodulators of inflammation, and are involved as regulatory molecules in infections, including sepsis. Treatment of sepsis is very complex and remains largely challenging and sometimes ineffective. This creates a need to develop new therapeutic strategies focusing not only on the elimination of sepsis-causing microorganisms, which can be achieved with antibiotics, but…

  52. 57.

    Golec M, Lemieszek MK, Dutkiewicz J, Milanowski J, et al. · International journal of molecular sciences · 2022 · PMID 36012117

    Over two billion people worldwide are exposed to organic dust, which can cause respiratory disorders. The discovery of the cathelicidin peptide provides novel insights into the lung's response to organic dust; however, its role in the lung's response to organic dust exposure and chronic lung diseases remains limited. We conducted a scoping review to map the current evidence on the role of cathelicidin LL-37/CRAMP in response to organic dust exposure and related chronic lung diseases: hypersensit…

  53. 58.

    Liu Q, Xu P, Zhang C · Immunity, inflammation and disease · 2026 · PMID 42095322

    Human cathelicidin peptide LL-37 is encoded by the CAMP gene and plays a key role in innate immunity. It maintains intestinal homeostasis through antibacterial, immunomodulation, and tissue repair functions. This paper reviews the multiple functions of LL-37 in the intestinal-immune axis and its contribution to intestinal immune homeostasis. A large amount of evidence shows that the biological effect of LL-37 is highly dependent on the environmental background, and its effects vary with peptide…

  54. 59.

    Chen K, Gong W, Huang J, Yoshimura T, et al. · Frontiers in bioscience (Landmark edition) · 2021 · PMID 34856773

    Human cathelicidin antimicrobial peptide LL-37 (LL-37) is an antimicrobial peptide derived from its precursor protein hCAP18, which is an only cathelicidin in human. LL-37 not only serves as a mediator of innate immune defense against invading microorganisms, but it also plays an essential role in tissue homeostasis, regenerative processes, regulation of proinflammatory responses, and inhibition of cancer progression. Therefore, LL-37 has been considered as a drug lead for diseases. However, hig…

  55. 60.

    Deng G, Luo Y, Wu W, Ru Y, et al. · Autoimmunity reviews · 2026 · PMID 43003168

    Antimicrobial peptides (AMPs) are a crucial component of the host immune defense system. Recent evidence has revealed that the antimicrobial peptide LL-37 exhibits a broad range of biological functions, including immunomodulatory roles in various diseases such as infectious diseases, cancers, cardiovascular diseases, and dermatological disorders. This review comprehensively examines the mechanisms of LL-37 in psoriasis and its comorbidities, highlighting its position within the disease network.…

  56. 61.

    Yin H, Lu Y · Clinical, cosmetic and investigational dermatology · 2026 · PMID 42861262

    This critical narrative review examines evidence relevant to LL-37-Mas-related G protein-coupled receptor X2 (MRGPRX2)-mast-cell signaling in rosacea and considers the relevance of these findings to future human studies. Literature was identified through PubMed and Web of Science Core Collection searches, supplemented by examination of reference lists from relevant original studies and recent reviews. Human rosacea tissue studies show changes in mast-cell abundance or degranulation-associated st…

  57. 62.

    J M, Veeraraghavan VP, Govindarajan S · Odontology · 2026 · PMID 42763374

    LL-37 is an antimicrobial peptide involved in antimicrobial defence, inflammatory regulation, tissue repair, and bone regeneration in the oral cavity. Salivary and gingival crevicular fluid LL-37 levels are associated with disease activity and treatment responses. Although there is solid mechanistic and preclinical data on LL-37, research on clinical applications of this remarkable peptide seem to be stalled due to a multitude of factors. The use of LL-37 in clinical practice is affected by prot…

  58. 63.

    Voronko OE, Novikova VS, Klychkova OO, Markina MP, et al. · International journal of molecular sciences · 2026 · PMID 42794783

    This review summarizes current knowledge on the role of human cathelicidin LL-37 in the regulation of apoptosis. LL-37 can modulate programmed cell death pathways, exerting either proapoptotic or antiapoptotic effects depending on various factors, such as cell type and peptide concentration. Data on LL-37 derivatives and their involvement in apoptosis are also discussed. Understanding the molecular mechanisms underlying LL-37 regulation of apoptosis is necessary to expand the therapeutic potenti…

  59. 64.

    Asti AL · International journal of molecular sciences · 2026 · PMID 42353177

    Physiologically produced circulating β-amyloid (Aβ) exerts critical physiological functions. Although Aβ is a key player in Alzheimer's disease (AD), it may initially be beneficial at the onset of infection. As an evolutionary conserved antimicrobial peptide (AMP), Aβ contributes to innate immune defense against pathogens. Host defense peptides such as Aβ and human cathelicidin (LL-37) not only kill pathogens through their antimicrobial activity but also exhibit high affinity for bacterial lipop…

  60. 65.

    Dave K, Thapa P · Archives of microbiology · 2026 · PMID 42183878

    The increasing incidence of antimicrobial resistance (AMR) in Gram-negative bacteria has become a significant global health issue, driven primarily by the structural and adaptive characteristics of lipopolysaccharide (LPS) in the outer membrane. As a robust permeability barrier, LPS limits the entry of various antimicrobial agents; furthermore, adaptive alterations to the chemical configuration of lipid A and related compounds augment bacterial resistance to both conventional antibiotics and hos…

Research Articles

167
  1. 66.

    Aidoukovitch A, Bankell E, Svensson D, Nilsson BO · Biochemical and biophysical research communications · 2024 · PMID 38642493

    The human cathelicidin LL-37 shows activity against microorganisms, but it is also cytotoxic to host cells. The CAMP gene codes for the LL-37 precursor hCAP18 which is processed extracellularly to active LL-37. It has previously been shown that vitamin D stimulates CAMP gene activity, but less information is available demonstrating that vitamin D also can increase hCAP18/LL-37 protein production. Here, we show with RT-qPCR that a physiological concentration of vitamin D (50 nM) enhances CAMP mRN…

  2. 67.

    Radic M, Muller S · Cells · 2022 · PMID 35954305

    Innate immunity responds to infections and inflammatory stimuli through a carefully choreographed set of interactions between cells, stimuli and their specific receptors. Of particular importance are endogenous peptides, which assume roles as defensins or alarmins, growth factors or wound repair inducers. LL-37, a proteolytic fragment of cathelicidin, fulfills the roles of a defensin by inserting into the membranes of bacterial pathogens, functions as alarmin in stimulating chemotaxis of innate…

  3. 68.

    Jackmann N, Englund S, Frisk P, Mäkitie O, et al. · British journal of haematology · 2022 · PMID 35849644

    The human cathelicidin hCAP-18 (pro-LL-37) is the pro-protein of the antimicrobial peptide LL-37. hCAP-18 can be produced by many different cell types; bone marrow neutrophil precursors are the main source of hCAP-18 in the circulation. Neutrophil count is used as a marker for myelopoiesis but does not always reflect neutrophil production in the bone marrow, and thus additional markers are needed. In this study, we established the reference interval of serum hCAP-18 level in healthy children and…

  4. 69.

    Mirzadzare N, Blyth GAD, Hannawayya R, Cirone KM, et al. · Gut microbes · 2025 · PMID 40735968

    Colonic goblet cells play a crucial role in mucosal defense by secreting Muc2 mucin and other proteins that entrap and expel enteropathogens. However, the role of innate effectors in the gut like cathelicidin peptides in regulating the mucus barrier during infections remains unclear. In this study, we used cathelicidin-deficient (

  5. 70.

    Suzuki K, Ohkuma M, Nagaoka I · Bioscience, biotechnology, and biochemistry · 2025 · PMID 40690262

    Endothelial-to-mesenchymal transition (EndMT) is a process that causes endothelial cells (ECs) to lose their EC characteristics and transform into mesenchymal cells. Accumulating studies suggest that EndMT is induced in atherosclerotic plaques and contributes to the pathogenesis of atherosclerosis. LL-37 is a multifaceted peptide with antimicrobial and immunomodulatory actions. Interestingly, LL-37 is localized in atherosclerotic plaques, suggesting an association between EndMT and LL-37 in athe…

  6. 71.

    Cerps S, Ramu S, Gidlöf O, Menzel M, et al. · Biochemistry and biophysics reports · 2025 · PMID 40612001

    The human cathelicidin LL-37 is active against both bacteria and viruses, but it also shows immunomodulatory properties. Here, we assess the impact of LL-37 on viral signaling in human airway epithelial BEAS-2B cells infected with the respiratory pathogen rhinovirus (RV). We show that LL-37 (4 μM) enhances RV-induced expression of interferon β (IFNβ) transcript and reduces viral-load. LL-37-evoked potentiation of RV-stimulated IFNβ does not involve up-regulation of the classical viral TLR3, MDA5…

  7. 72.

    Sørensen OE, Follin P, Johnsen AH, Calafat J, et al. · Blood · 2001 · PMID 11389039

    Cathelicidins are a family of antimicrobial proteins found in the peroxidase-negative granules of neutrophils. The known biologic functions reside in the C-terminus, which must be cleaved from the holoprotein to become active. Bovine and porcine cathelicidins are cleaved by elastase from the azurophil granules to yield the active antimicrobial peptides. The aim of this study was to identify the physiological setting for cleavage of the only human cathelicidin, hCAP-18, to liberate the antibacter…

  8. 73.

    Seminario AL, Karczewski AE, Chung W, Wang Y, et al. · Biomedicine hub · 2024 · PMID 38287973

    Human cathelicidin LL-37 is a salivary antimicrobial peptide (AMP) with broad-spectrum activity against oral diseases, but few studies have assessed its role in children and adolescents living with HIV (CALHIV). We assessed salivary LL-37 levels and correlates in a long-term cohort of Kenyan CALHIV followed since antiretroviral therapy (ART) initiation. Saliva was collected from 76 CALHIV who were recruited from two ongoing pediatric HIV studies in Nairobi, Kenya. Oral examinations documenting o…

  9. 74.

    Kilari G, Tran J, Blyth GAD, Cobo ER · Biochimica et biophysica acta. Biomembranes · 2025 · PMID 39837472

    The intestinal barrier, held together by epithelial cells and intercellular tight junction (TJ) proteins, prevents the penetration of microbial pathogens. Concurrently, intestinal epithelial cells secrete antimicrobial peptides, including cathelicidin. Cathelicidin has direct antibacterial and immunomodulatory functions, although its role in intestinal integrity remains elusive. In this study, we demonstrate that direct stimulation of human colonic epithelial (T84) cells with human cathelicidin,…

  10. 75.

    Suzuki K, Ohkuma M, Someya A, Mita T, et al. · Journal of immunology (Baltimore, Md. : 1950) · 2022 · PMID 35387840

    Human cathelicidin LL-37 is an antimicrobial peptide that has a broad spectrum of antimicrobial activities but also acts on host cells to exert immunomodulatory functions. It has been suggested that the increase of LL-37 in atherosclerotic aortas and the dysregulated autophagy of endothelial cells are involved in the pathogenesis of atherosclerosis. In this study, to elucidate the role of LL-37 in atherosclerosis, we investigated the effect of LL-37 on autophagy in endothelial cells using HUVECs…

  11. 76.

    Xi L, Du J, Xue W, Shao K, et al. · Peptides · 2024 · PMID 38423213

    Diabetic patients often experience impaired wound healing. Human cathelicidin LL-37 possesses various biological functions, such as anti-microbial, anti-inflammatory, and pro-wound healing activities. Autophagy has important effects on skin wound healing. However, little is known about whether LL-37 accelerates diabetic wound healing by regulating autophagy. In the study, we aimed to investigate the role of autophagy in LL-37-induced wound healing and uncover the underlying mechanisms involved.…

  12. 77.

    Ahmed EM, Boseila AA, Hanora AS, Solyman SM · Cellular and molecular biology (Noisy-le-Grand, France) · 2024 · PMID 39262269

    Rift Valley Fever Virus (RVFV) is an arbovirus that circulates among animals and can be transmitted to humans. Mosquitoes are the primary vectors that allow RVFV to spread vertically and horizontally. Egypt was exposed to frequent outbreaks with devastating economic consequences. RVFV has a high incidence of worldwide dissemination and no specific vaccine or therapy. Linear Human Cathelicidin (LL-37), is a natural antimicrobial peptide with antiviral activity against numerous viruses. In additio…

  13. 78.

    Zhang H, Zhen J, Zhang R, Wanyan Y, et al. · Cell death discovery · 2022 · PMID 35039485

    Cathelicidin hCAP18/LL-37 can resist infection from various pathogens and is an essential component of the human immune system. Accumulating evidence has indicated that hCAP18/LL-37 plays a tissue-specific role in human cancer. However, its function in hepatocellular carcinoma (HCC) is poorly understood. The present study investigated the effects of hCAP18/LL-37 on HCC in vitro and in vivo. Results showed that hCAP18/LL-37 overexpression significantly promoted the proliferation of cultured HCC c…

  14. 79.

    Su Y, Sharma NS, John JV, Ganguli-Indra G, et al. · Advanced healthcare materials · 2022 · PMID 35930707

    Exosomes show great potential in diagnostic and therapeutic applications. Inspired by the human innate immune defense, herein, we report engineered exosomes derived from monocytic cells treated with immunomodulating compounds 1α,25-dihydroxyvitamin D

  15. 80.

    von Haussen J, Koczulla R, Shaykhiev R, Herr C, et al. · Lung cancer (Amsterdam, Netherlands) · 2008 · PMID 17764778

    Cancer development can be viewed as dysregulated repair. Antimicrobial peptides (AMPs) are effector molecules of the innate immune system with direct antimicrobial activity. Beside this host defence function several AMPs play a role in the regulation of inflammation and tissue repair. The aim of the present study was to investigate whether the human cathelicidin AMP LL-37/hCAP-18 is involved in the biology of lung cancer. Human cancer cell lines were found to express the human cathelicidin LL-37…

  16. 81.

    Fang Y, Zhang Z, Cao Q, Wang G, et al. · Science China. Life sciences · 2026 · PMID 40971038

    Dysregulation of low-density lipoprotein (LDL) cholesterol is strongly correlated with the risk of metabolic dysfunction-associated steatotic liver disease. Endogenous molecules targeting LDL clearance play crucial roles in the progression of liver steatosis. Human cathelicidin LL-37 can form complexes with lipoproteins, but whether these complexes regulate lipoprotein-driven cholesterol metabolism is not clear. Here, we find that cathelicidin LL-37 binds to LDL via apolipoprotein (Apo)B-100 dom…

  17. 82.

    Jiang X, Yang C, Qiu J, Ma D, et al. · Nanoscale · 2022 · PMID 36413063

    LL-37, the only human host cathelicidin peptide, is proposed to be able to induce host cell apoptosis through mitochondrial membrane permeabilization (MMP). Detailed pathways of the LL-37-triggered MMP are however still disputed. It is generally believed that cationic peptides permeate a membrane mostly in conditions of micromolar peptide concentrations and negatively charged membranes, which are not usually satisfied in the mitochondrial circumstance. Herein, using a variety of single-molecule…

  18. 83.

    Ikutama R, Peng G, Tsukamoto S, Umehara Y, et al. · The Journal of investigative dermatology · 2023 · PMID 36455652

    Human cathelicidin LL-37 is a multifunctional antimicrobial peptide that exhibits antimicrobial and immunomodulatory activities. LL-37 regulates skin barrier function and was recently reported to activate autophagy in macrophages. Because autophagy deficiency is associated with skin diseases characterized by a dysfunctional epidermal barrier, we hypothesized that LL-37 might regulate the skin barrier through autophagy modulation. We showed that LL-37 activated autophagy in human keratinocytes an…

  19. 84.

    Shih CC, Liao WC, Ke HY, Kuo CW, et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023 · PMID 36958193

    Global warming increases the incidence of heat stroke (HS) and HS causes the reduction of visceral blood flow during hyperthermia, leading to intestinal barrier disruption, microbial translocation, systemic inflammation and multiple organ failure. Cathelicidin LL-37 exhibits antimicrobial activities, helps innate immunity within the gut to maintain intestinal homeostasis, and augments intestinal wound healing and barrier function. Thus, we evaluated the effects and possible mechanisms of catheli…

  20. 85.

    Liang J, Chen J, Ye Z, Bao D · Physiological research · 2022 · PMID 35616038

    Osteoporosis is a bone disease characterized by low bone mineral density (BMD) and impaired bone microarchitecture due to the abnormal activity of osteoclasts. Cathelicidins are antimicrobial peptides present in the lysosomes of macrophages and polymorphonuclear leukocytes. LL-37, a cathelicidin, induces various biological effects, including modulation of the immune system, angiogenesis, wound healing, cancer growth, as well as inflammation, and bone loss. A previous study reported direct involv…

  21. 86.

    Majewska M, Zamlynny V, Pieta IS, Nowakowski R, et al. · Bioelectrochemistry (Amsterdam, Netherlands) · 2021 · PMID 34049238

    The only representative of cathelicidin peptides in humans is LL-37, a multifunctional antimicrobial peptide (AMP) that is a part of the innate immune response. Details of the LL-37 direct activity against pathogens are not well understood at the molecular level. Here, we present research on the mechanism of interaction between LL-37 and a model multicomponent bilayer lipid membrane (BLM), mimicking microbial cell membrane. Electrochemical impedance spectroscopy (EIS), high-resolution atomic for…

  22. 87.

    Zhang H, Yuan X, Yang Y, Wanyan Y, et al. · Cell adhesion & migration · 2023 · PMID 36656313

    The effect of cathelicidin hCAP18/LL-37 in hepatocellular carcinoma (HCC) metastasis remains unclear. Here, we confirmed that LL-37 expression enhanced endothelial-mesenchymal transition (EMT), migration and invasion in HCC cells. And the HER2/EGFR-MAPK/ERK signal participated in the process above. More frequent lung metastases were observed in an LL-37-overexpressing hematogenous metastasis model. Interestingly, 1,25(OH)

  23. 88.

    Porto WF, Alencar SA · Journal of molecular graphics & modelling · 2023 · PMID 36335830

    Cathelicidin antimicrobial peptides are a diverse family of cationic amphipathic peptides with multiple activities. In humans, cathelicidin LL-37 is one of the main host defense peptides with a remarkable medical and biotechnological potential. Deregulation of LL-37 expression has been associated with inflammatory diseases. However the effects of point mutations driven by single nucleotide polymorphisms (SNPs) on LL-37 are unknown. Here we applied an array of computational tools to investigate t…

  24. 89.

    Matsumura T, Sugiyama N, Murayama A, Yamada N, et al. · Hepatology research : the official journal of the Japan Society of Hepatology · 2016 · PMID 26606891

    Although recent studies indicate that supplementation with vitamin D (VD) potentiates a sustained viral response by interferon-based therapy to chronic hepatitis C, detailed mechanisms are not fully defined. The production of cathelicidin, an antimicrobial peptide, has been demonstrated to be part of the VD-dependent antimicrobial pathway in innate immunity. Cathelicidin is known to directly kill or inhibit the growth of microbial pathogens including mycobacteria and viruses. We used a hepatitis…

  25. 90.

    Simonetti O, Cirioni O, Goteri G, Lucarini G, et al. · Antibiotics (Basel, Switzerland) · 2021 · PMID 34680791

    LL-37 is the only human antimicrobial peptide that belongs to the cathelicidins. The aim of the study was to evaluate the efficacy of LL-37 in the management of MRSA-infected surgical wounds in mice. A wound on the back of adult male BALB/c mice was made and inoculated with Histological examination of wounds in the group treated with topical and intraperitoneal LL-37 showed increased re-epithelialization, formation of the granulation tissue, collagen organization, and angiogenesis. Based on the…

  26. 91.

    Svensson D, Lagerstedt JO, Nilsson BO, Del Giudice R · Biochemical and biophysical research communications · 2017 · PMID 28919413

    The human cathelicidin peptide LL-37 has antimicrobial and anti-biofilm functions, but LL-37 may also damage the host by triggering inflammation and exerting a cytotoxic effect, thereby reducing host cell viability. Human plasma mitigates LL-37-induced host cell cytotoxicity but the underlying mechanisms are not completely understood. Apolipoprotein A-I (ApoA-I) is a plasma protein endowed with atheroprotective effects. Here, we investigate the interaction between ApoA-I and LL-37 by biochemical…

  27. 92.

    Lee JY, Hong YK, Ko KS · Diagnostic microbiology and infectious disease · 2020 · PMID 32019695

    In this study, we demonstrated the development of colistin dependence in Acinetobacter baumannii isolates after exposure to the human cationic antimicrobial peptide LL-37. The LL-37-induced colistin-dependent mutants showed susceptibility to many other antibiotics and IS1595 or ATTT insertions in LpxACD.

  28. 93.

    Bi Z, Ren W, Zeng H, Zhou Y, et al. · Cell proliferation · 2025 · PMID 40375579

    Continual evolution of SARS-CoV-2 spike drives the emergence of Omicron variants that show increased spreading and immune evasion. Understanding how the variants orientate themselves towards host immune defence is crucial for controlling future pandemics. Herein, we demonstrate that human cathelicidin LL-37, a crucial component of innate immunity, predominantly binds to the S2 subunit of SARS-CoV-2 spike protein, occupying sites where TMPRSS2 typically binds. This binding impedes TMPRSS2-mediate…

  29. 94.

    Si F, Lu Y, Wen Y, Chen T, et al. · Immunity, inflammation and disease · 2023 · PMID 37773705

    Kawasaki disease (KD) is a type of vasculitis with an unidentified etiology. Cathelicidin (LL-37) may be involved in the development of the KD process; therefore, further research to investigate the molecular mechanism of LL-37 involvement in KD is warranted. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, NLRP3, and LL-37 in the sera of healthy subjects, children with KD, and children with pneumonia. Subsequently,…

  30. 95.

    Wang C, Li M, Xia X, Fu Y, et al. · Antiviral research · 2024 · PMID 38460762

    Zika virus (ZIKV) is an enveloped, single-stranded and positive-stranded RNA virus of the genus Flavivirus in the family Flaviviridae. ZIKV can cross the placental barrier and infect the fetus, causing microcephaly, congenital ZIKV syndrome, and even fetal death. ZIKV infection can also lead to testicular damage and male sterility. But no effective drugs and vaccines are available up to now. Previous studies have shown that the cathelicidin antimicrobial peptide LL-37 can protect against ZIKV in…

  31. 96.

    Croitoru DO, Piguet V · The Journal of investigative dermatology · 2021 · PMID 34565561

    Microbes and commensal mites contribute to the development of inflammation and neurovascular dysregulation in rosacea. Cathelicidin family proteins are epithelial antimicrobial peptides expressed in higher-order mammals. In humans, mature LL-37 is cleaved from its precursor in response to microbial infection, UV light, and injury. In their new article in the Journal of Investigative Dermatology, Yoon et al. expand on existing evidence supporting LL-37 proinflammatory activity in lipopolysacchari…

  32. 97.

    Koczulla R, von Degenfeld G, Kupatt C, Krötz F, et al. · The Journal of clinical investigation · 2003 · PMID 12782669

    Antimicrobial peptides are effector molecules of the innate immune system and contribute to host defense and regulation of inflammation. The human cathelicidin antimicrobial peptide LL-37/hCAP-18 is expressed in leukocytes and epithelial cells and secreted into wound and airway surface fluid. Here we show that LL-37 induces angiogenesis mediated by formyl peptide receptor-like 1 expressed on endothelial cells. Application of LL-37 resulted in neovascularization in the chorioallantoic membrane as…

  33. 98.

    Amagai R, Takahashi T, Terui H, Fujimura T, et al. · International journal of molecular sciences · 2023 · PMID 36614313

    An active form of cathelicidin antimicrobial peptide, LL-37, has immunomodulatory and stimulatory effects, though the specific pathways are not clear. The purpose of this study was to identify the cellular pathways by which LL-37 amplifies the inflammation induced by damage-associated molecular patterns (DAMPs). We performed DNA microarray, reverse transcription polymerase chain reaction, immunoblotting, and proximity ligation assays using cultured keratinocytes treated with LL-37 and/or the DAM…

  34. 99.

    Wollny T, Wnorowska U, Piktel E, Suprewicz Ł, et al. · International journal of molecular sciences · 2022 · PMID 35806446

    It has been proven that tumour growth and progression are regulated by a variety of mediators released during the inflammatory process preceding the tumour appearance, but the role of inflammation in the development of bladder cancer is ambiguous. This study was designed around the hypothesis that sphingosine-1-phosphate (S1P), as a regulator of several cellular processes important in both inflammation and cancer development, may exert some of the pro-tumorigenic effects indirectly due to its ab…

  35. 100.

    Nell MJ, Tjabringa GS, Vonk MJ, Hiemstra PS, et al. · FEMS immunology and medical microbiology · 2004 · PMID 15364108

    The respiratory epithelium plays a major role in the primary defense of the airways against infection. It has been demonstrated that bacterial products are involved in the induction of inflammatory reactions of the upper airways. Little is known about the effects of bacterial products on expression of the antimicrobial peptide hCAP-18/LL-37, the only human cathelicidin identified so far. The aim of this study was to investigate the effects of bacterial products from both gram-positive and gram-n…

  36. 101.

    Duan Z, Zhang J, Chen X, Liu M, et al. · Cellular and molecular life sciences : CMLS · 2022 · PMID 35596804

    Blood clot formation induced by dysfunctional coagulation is a frequent complication of coronavirus disease 2019 (COVID-19) and a high-risk factor for severe illness and death. Neutrophil extracellular traps (NETs) are implicated in COVID-19-induced immunothrombosis. Furthermore, human cathelicidin, a NET component, can perturb the interaction between the SARS-CoV-2 spike protein and its ACE2 receptor, which mediates viral entry into cells. At present, however, the levels of cathelicidin antimic…

  37. 102.

    Kozłowska E, Wysokiński A, Brzezińska-Błaszczyk E · Psychiatry research · 2017 · PMID 28550757

    Cathelicidin LL-37 is a small cationic that plays an important role in antimicrobial defense, as it kills a broad spectrum of infectious agents by disrupting their membranes, including gram-positive and gram-negative bacteria, some viruses and fungi; and it neutralizes activity of bacterial endotoxins. Moreover, cathelicidin LL-37 exerts proinflammatory effect, while numerous reports indicate the role of inflammation in the development of depression. The purpose of this study was to evaluate the…

  38. 103.

    Fang X, Nong K, Wang Z, Jin Y, et al. · Peptides · 2023 · PMID 36370932

    Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 infection impairs intestinal barrier function, causing intestinal inflammation and enteric dysbacteriosis. The human cathelicidin LL-37 can regulate excessive inflammatory responses, barrier function, and balance the intestinal microbial community; however, little is known about its effects on inflammation, intestinal barrier function, and microbiota disorders in EHEC O157:H7-infected mice. In this study, we investigated the protective effect of…

  39. 104.

    Cheah CW, Al-Maleki AR, Vadivelu J, Danaee M, et al. · International journal of rheumatic diseases · 2020 · PMID 32743970

    Rheumatoid arthritis (RA) is associated with chronic periodontitis (CP) due to shared risk factors, immuno-genetics and tissue destruction pathways. Human cathelicidin LL-37 has been suggested as a possible mechanistic link for these diseases. This study investigated the levels of salivary and serum LL-37 in subjects with RA and CP and their correlation with disease parameters. Subjects were allocated into RA (n = 49) or non-RA (NRA) (n = 55) groups, where 3 subgroups were further established; c…

  40. 105.

    Kalimuthu S, Pudipeddi A, Braś G, Tanner JA, et al. · APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2023 · PMID 37150907

    Yeasts such as Candida albicans, albeit being ubiquitous members of the skin, oral and vaginal microbiome, can cause superficial to life-threatening infections. Human cathelicidin LL-37-based peptides have antibacterial activity and yet, their antifungal activity remains to be thoroughly characterized. The aim of this study was to comprehensively investigate the activity of LL-37-based peptides against C. albicans. LL-37 and its derivatives were tested for their ability to kill C. albicans plank…

  41. 106.

    Guo YJ, Zhang B, Feng XS, Ren HX, et al. · BMC oral health · 2016 · PMID 27659310

    Streptococcus mutans forms biofilms as a resistance mechanism against antimicrobial agents in the human oral cavity. We recently showed that human cathelicidin LL-37 exhibits inhibitory effects on biofilm formation of S. mutans through interaction with lipoteichoic acid (LTA), but without antibacterial or biofilm dispersal abilities. (-)-Epigallocatechin gallate (EGCG) is the most abundant constituent of tea catechins that has the greatest anti-infective potential to inhibit the growth of variou…

  42. 107.

    Wlodarczyk J, Dziki L, Fichna J · Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2025 · PMID 41569060

    Colorectal cancer (CRC) remains a major global health challenge, with increasing incidence and limited treatment options. The antimicrobial peptide cathelicidin (LL-37) has been implicated in both tumorigenic and tumor-suppressive roles, but its precise function in CRC progression remains unclear. This study investigates the LL-37 expression in CRC and its association with key molecular pathways, including vitamin D signaling and G protein-coupled receptors (GPCRs). We analyzed LL-37 mRNA expres…

  43. 108.

    Abdelaal NH, Rashed LA, Ibrahim SY, Abd El Halim MH, et al. · Medical mycology · 2017 · PMID 27915299

    Antimicrobial peptides (AMPs) are considered an important first line of defense against pathogens. Cathelicidin LL-37 was upregulated in response to fungal infection. In this work we aimed to evaluate cathelicidin LL-37 in the hair of tinea capitis and compare it to normal controls. Hair samples were collected from 30 children and 30 controls aged from 2 to10 years old, and the level of cathelicidin LL-37 in the hair was detected by quantitative real-time PCR. The 30 patients were further subdiv…

  44. 109.

    Salzer S, Kresse S, Hirai Y, Koglin S, et al. · Journal of dermatological science · 2014 · PMID 25306296

    In patients with rosacea, environmental stressors, especially UVB radiation, trigger disease flares that are characterized by inflammation and vascular hyperactivity. An altered innate immune detection and response system, modulated to a large extent by the aberrant production and processing of human cathelicidin LL-37, is thought to play a central role in disease pathogenesis. To investigate whether the proinflammatory and proangiogenic effects of UV radiation are enhanced in the presence of ca…

  45. 110.

    Su W, Chen Y, Wang C, Ding X, et al. · Biochemical and biophysical research communications · 2016 · PMID 27012197

    Biological functions of human cathelicidin LL-37 have been widely reported, including antibacterial, immune and anti-tumor effects. However, the antiplatelet activity of LL-37 has not been addressed. The purpose of our study was to investigate the antiplatelet and antithrombotic actions of LL-37. We found that this peptide inhibited human platelet aggregation in vitro and attenuated thrombus formation in vivo. Furthermore, LL-37 reduced phosphorylation of Src kinase and Akt(Ser473), decreased pl…

  46. 111.

    Li K, Tao N, Zheng L, Sun T · International immunopharmacology · 2020 · PMID 31877496

    Glucocorticoids play a key role in treatment of inflammatory lung diseases including both airway and parenchymal lung diseases. RNA viral infections are major causes of chronic lung disease exacerbations and can determine glucocorticoid resistance. The antibacterial peptide LL-37, the only member of human cathelicidin family, also functions as antiviral-activity enhancer. However, whether it can alleviate the glucocorticoid resistance caused by RNA viruses remains unclear. Here, we used type I (…

  47. 112.

    Zhang Z, Chen WQ, Zhang SQ, Bai JX, et al. · Frontiers in pharmacology · 2022 · PMID 35935871

    Pancreatic cancer is amongst the most lethal malignancies, while its poor prognosis could be associated with promotion of autophagy and the tumor immune microenvironment. Studies have confirmed the pro-tumorigenic nature of the cathelicidin family of peptide LL-37 in several types of cancer. However, at higher doses, LL-37 exerts significant cytotoxicity against gastrointestinal cancer cells. In our study, we investigated the anti-tumorigenic potential of LL-37 in pancreatic cancer and the under…

  48. 113.

    Sheehan G, Bergsson G, McElvaney NG, Reeves EP, et al. · Infection and immunity · 2018 · PMID 29712727

    The pulmonary mucus of cystic fibrosis (CF) patients displays elevated levels of the cathelicidin antimicrobial peptide LL-37, and the aim of this work was to assess the effect of LL-37 on the growth of

  49. 114.

    Cirone KM, Lahiri P, Holani R, Tan YL, et al. · Cell and tissue research · 2020 · PMID 31478135

    Mycobacterium avium subsp. paratuberculosis (MAP) causes chronic diarrheic intestinal infections in domestic and wild ruminants (paratuberculosis or Johne's disease) for which there is no effective treatment. Critical in the pathogenesis of MAP infection is the invasion and survival into macrophages, immune cells with ability to carry on phagocytosis of microbes. In a search for effective therapeutics, our objective was to determine whether human cathelicidin LL-37, a small peptide secreted by l…

  50. 115.

    Reinholz M, Ruzicka T, Schauber J · Annals of dermatology · 2012 · PMID 22577261

    Chronic inflammatory skin diseases such as atopic dermatitis, psoriasis or rosacea are very common. Although their exact pathogenesis is not completely understood all three diseases are characterized by dysregulation of cutaneous innate immunity. Cathelicidin LL-37 is an important effector molecule of innate immunity in the skin and atopic dermatitis, psoriasis or rosacea show defects in cathelicidin expression, function or processing. In atopic dermatitis, cathelicidin induction might be distur…

  51. 116.

    Mader JS, Ewen C, Hancock RE, Bleackley RC · Journal of immunotherapy (Hagerstown, Md. : 1997) · 2011 · PMID 21389875

    LL-37 is a human cationic host defense peptide (antimicrobial peptide) belonging to the cathelicidin family of peptides. In this study, LL-37 was shown to kill stimulated and nonstimulated CD4(+)CD25(+)FoxP3(+) T cells (regulatory T cells; Tregs) through apoptosis, while having no cytotoxic effect on CD4(+)CD25(-) T cells at the same LL-37 concentrations. Of interest, Tregs were much more sensitive to LL-37 than many other cells, dying at 10-fold lower concentrations than other cell types tested…

  52. 117.

    Hou X, Li C, Liu J, Yang S, et al. · Infection and immunity · 2024 · PMID 38501672

  53. 118.

    Rather IA, Sabir JSM, Asseri AH, Ali S · Journal of fungi (Basel, Switzerland) · 2022 · PMID 35205958

  54. 119.

    Mader JS, Marcet-Palacios M, Hancock RE, Bleackley RC · Experimental cell research · 2011 · PMID 21134367

    LL-37 is a human cationic host defense peptide (antimicrobial peptide) belonging to the cathelicidin family of peptides. In this study, LL-37 was shown to kill stimulated CD8(+) T cells (Cytotoxic T lymphocytes; CTLs) via apoptosis, while having no cytotoxic effect on non-stimulated CD8(+) or CD4(+) T cells or stimulated CD4(+) T cells. Of interest, the CD8(+) cells were much more sensitive to LL-37 than many other cell types. LL-37 exposure resulted in DNA fragmentation, chromatin condensation,…

  55. 120.

    Chakraborty K, Ghosh S, Koley H, Mukhopadhyay AK, et al. · Cellular microbiology · 2008 · PMID 18717821

    Cathelicidin (hCAP-18/LL-37) and beta-defensin 1 (HBD-1) are human antimicrobial peptides (AMPs) with high basal expression levels, which form the first line of host defence against infections over the epithelial surfaces. The antimicrobial functions owe to their direct microbicidal effects as well as the immunomodulatory role. Pathogenic microorganisms have developed multiple modalities including transcriptional repression to combat this arm of the host immune response. The precise mechanisms a…

  56. 121.

    Nijnik A, Pistolic J, Wyatt A, Tam S, et al. · Journal of immunology (Baltimore, Md. : 1950) · 2009 · PMID 19812202

    The human cathelicidin peptide LL-37 is a multifunctional immunomodulatory and antimicrobial host defense peptide of the human immune system. LL-37 modulates host cell responses to microbial stimuli and also affects the action of other endogenous immune mediators such as IL-1beta and GM-CSF. This activity of LL-37 is known to be complex, with the functional outcomes being dependent on the cell type and activation status, timing of exposure, and other immune mediators present. It was demonstrated…

  57. 122.

    Lee IH, Jung YJ, Cho YG, Nou IS, et al. · PloS one · 2017 · PMID 28282452

    Human LL-37 is a multifunctional antimicrobial peptide of cathelicidin family. It has been shown in recent studies that it can serve as a host's defense against influenza A virus. We now demonstrate in this study how signal peptide LL-37 (SP-LL-37) can be used in rice resistance against bacterial leaf blight and blast. We synthesized LL-37 peptide and subcloned in a recombinant pPZP vector with pGD1 as promoter. SP-LL-37 was introduced into rice plants by Agrobacterium mediated transformation. S…

  58. 123.

    Esposito TVF, Rodríguez-Rodríguez C, Blackadar C, Kłodzińska S, et al. · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2024 · PMID 38972467

    Human cathelicidin LL-37, a cationic host defense peptide (CHDP), has several important physiological roles, including antimicrobial activity, immune modulation, and wound healing, and is a being investigated as a therapeutic candidate for several indications. While the effects of endogenously produced LL-37 are well studied, the biodistribution of exogenously administered LL-37 are less known. Here we assess the biodistribution of a gallium-67 labeled variant of LL-37 using nuclear imaging tech…

  59. 124.

    Frew L, Makieva S, McKinlay AT, McHugh BJ, et al. · PloS one · 2014 · PMID 25089904

    hCAP18/LL-37 is the sole human cathelicidin; a family of host defence peptides with key roles in innate host defence. hCAP18/LL-37 is expressed primarily by neutrophils and epithelial cells, but its production and function in the lower genital tract is largely uncharacterised. Despite the significant roles for cathelicidin in multiple organs and inflammatory processes, its impact on infections that could compromise fertility and pregnancy is unknown. The aim of this study was to investigate cath…

  60. 125.

    Amatngalim GD, Nijnik A, Hiemstra PS, Hancock RE · Inflammation · 2011 · PMID 20811938

    Inflammatory diseases remain an important cause of morbidity and mortality. Cathelicidins are immunomodulatory and antimicrobial peptides with potent anti-endotoxic properties. Although the effects of the human cathelicidin LL-37 on cellular responses to Toll-like receptor (TLR) ligands have been investigated, its effects on responses to other pro-inflammatory stimuli have not been well studied. Triggering receptor expressed on myeloid cells (TREM-1) acts to amplify inflammatory responses and pl…

  61. 126.

    Gedik AH, Cakir E, Gokdemir Y, Uyan ZS, et al. · The clinical respiratory journal · 2017 · PMID 26073571

    The antimicrobial peptides (AMPs) human β-defensins and cathelicidin (LL-37) are key factors in innate and adaptive immune responses of the respiratory tract and play an important role in many respiratory diseases. No data are available in the literature about the levels of these AMPs in paediatric patients with post-infectious bronchiolitis obliterans (BO). This study aimed to determine human β-defensin 2 (hBD2) and LL-37 levels and compare between post-infectious BO patients and the control gr…

  62. 127.

    Türkoğlu O, Emingil G, Kütükçüler N, Atilla G · Journal of periodontology · 2009 · PMID 19485828

    Cathelicidin LL-37, an antimicrobial peptide, is part of the host innate immune response in the oral cavity. Interleukin (IL)-18, a proinflammatory cytokine, could play a role in the progression of the inflammatory response. The aim of the present study was to determine the levels of cathelicidin LL-37 and IL-18 in the gingival crevicular fluid (GCF) of patients with gingivitis and chronic periodontitis. Fifty-nine subjects were included in the present study. Probing depth (PD), clinical attachm…

  63. 128.

    Wan M, van der Does AM, Tang X, Lindbom L, et al. · Journal of leukocyte biology · 2014 · PMID 24550523

    LL-37/hCAP-18 is the only human member of the cathelicidin family and plays an important role in killing various pathogens, as well as in immune modulation. In this study, we investigated the effect of LL-37 on bacterial phagocytosis by macrophages and demonstrate that LL-37 enhances phagocytosis of IgG-opsonized Gram-negative and Gram-positive bacteria in a dose- and time-dependent manner by dTHP-1 cells. In addition, LL-37 enhanced phagocytosis of nonopsonized Escherichia coli by human macroph…

  64. 129.

    Kulkarni NN, O'Neill AM, Dokoshi T, Luo EWC, et al. · The Journal of biological chemistry · 2021 · PMID 34048712

    Cathelicidins such as the human 37-amino acid peptide (LL-37) are peptides that not only potently kill microbes but also trigger inflammation by enabling immune recognition of endogenous nucleic acids. Here, a detailed structure-function analysis of LL-37 was performed to understand the details of this process. Alanine scanning of 34-amino acid peptide (LL-34) showed that some variants displayed increased antimicrobial activity against Staphylococcus aureus and group A Streptococcus. In contrast…

  65. 130.

    Johansson L, Thulin P, Sendi P, Hertzén E, et al. · Infection and immunity · 2008 · PMID 18490458

    Severe soft tissue infections, such as necrotizing fasciitis and severe cellulitis, caused by group A streptococci (GAS) are rapidly progressing life-threatening infections characterized by massive bacterial loads in the tissue even late after the onset of infection. Antimicrobial peptides are important components of the innate host defense, and cathelicidins have been shown to protect against murine necrotic skin infections caused by GAS. However, it has been demonstrated that the streptococcal…

  66. 131.

    Otte JM, Zdebik AE, Brand S, Chromik AM, et al. · Regulatory peptides · 2009 · PMID 19328825

    The human cathelicidin LL-37 is involved in innate immune responses, angiogenesis and wound healing. Functions in maintenance and re-establishment of intestinal barrier integrity have not been characterized yet. Following direct and indirect stimulation of human colonic HT-29 and Caco-2 cells with LL-37 the cellular viability, rate of apoptosis, proliferation and wound healing were determined. Expression of mucins and growth factors was quantified by real-time PCR and Western blotting. Direct ap…

  67. 132.

    Pennone V, Angelini E, Sarlah D, Lovati AB · Antibiotics (Basel, Switzerland) · 2024 · PMID 39200064

    Open fractures and prosthetic joints are prone to bacterial infections, especially those involving biofilms, and are worsened by antibiotic inefficacy and resistance. This highlights the need for targeted treatments against orthopedic infections. LL-37, a human cathelicidin, is known for its antimicrobial properties. This study aimed to synthesize and evaluate LL-37-derived antimicrobial peptides (AMPs) for antibacterial efficacy and toxicity. Several truncated LL-37 analogues were created and t…

  68. 133.

    Salvado MD, Di Gennaro A, Lindbom L, Agerberth B, et al. · Arteriosclerosis, thrombosis, and vascular biology · 2013 · PMID 23766266

    LL-37, the unique cathelicidin expressed in humans, in addition to acting as an endogenous antibiotic, is an important cell-signaling molecule upregulated in ovarian, breast, and lung tumors. However, the role of LL-37 in tumor microenvironment and its specific actions on the endothelial compartment remain elusive. Prostanoids are key regulators of inflammation, and cyclooxygenases (COXs) display proangiogenic activity in vitro and in vivo, mediated principally through prostaglandin E2 (PGE2). H…

  69. 134.

    Choi KY, Napper S, Mookherjee N · Immunology · 2014 · PMID 24666281

    Human cathelicidin LL-37 protects against infections and endotoxin-induced inflammation. In a recent study we have shown that IG-19, an LL-37-derived peptide, protects in a murine model of arthritis. Cytokine interleukin-32 (IL-32) is elevated and directly associated with the disease severity of inflammatory arthritis. Therefore, in this study we examined the effects of LL-37 and IG-19 on IL-32-induced responses in human peripheral blood-derived mononuclear cells (PBMC) and macrophages. We showe…

  70. 135.

    Rekha RS, Padhi A, Frengen N, Hauenstein J, et al. · Cell reports · 2025 · PMID 39708316

    The human cathelicidin peptide LL-37 induces autophagy in human macrophages. Different post-translational modifications (PTMs) such as citrullination, acetylation, and formylation impact LL-37, yet their effect on autophagy remains unknown. Thus, we set out to study how the cellular source could impact PTM of LL-37 and subsequent effects on autophagy initiation. Neutrophil-released LL-37 failed to induce autophagy, unlike macrophage-released LL-37. Mass spectrometry analysis revealed modificatio…

  71. 136.

    Yang Y, Huang C, Hui L, Song Y, et al. · Journal of virology · 2023 · PMID 36916989

    Cathelicidin antimicrobial peptides (mouse, CRAMP; human, LL-37) have broad-spectrum antiviral activities against enveloped viruses, but their mechanisms of action against nonenveloped viruses remain to be elucidated. Coxsackievirus B3 (CVB3), a member of nonenveloped virus belonging to the

  72. 137.

    Jiang W, Sunkara LT, Zeng X, Deng Z, et al. · Peptides · 2013 · PMID 24140860

    LL-37 is the single cathelicidin host defense peptide in humans with direct antimicrobial and immunomodulatory activities. Specific regulation of LL-37 synthesis has emerged as a novel non-antibiotic approach to disease control and prevention. Short-chain fatty acids, and butyrate in particular, were found recently to be strong inducers of LL-37 gene expression without causing inflammation. Here, we further evaluated the LL-37-inducing efficiency of a broad range of saturated free fatty acids an…

  73. 138.

    Schauber J, Rieger D, Weiler F, Wehkamp J, et al. · European journal of gastroenterology & hepatology · 2006 · PMID 16702850

    Inflammatory bowel diseases (IBDs) are characterized by a breakdown of colon epithelial barrier function. Antimicrobial peptides like cathelicidins are molecules of the innate immune system located at epithelial surfaces. Cathelicidins influence microbial growth and inflammation and may play a role in IBD. In this study, the expression of human cathelicidin hCAP18/LL-37 was investigated in the intestinal mucosa from patients suffering from ulcerative colitis or Crohn's disease. Biopsy material f…

  74. 139.

    Babikir IH, Abugroun EA, Bilal NE, Alghasham AA, et al. · BMC infectious diseases · 2018 · PMID 29310594

    The defense mechanisms of the urinary tract are attributed mainly to the innate immune system and the urinary tract urothelium which represent the first line of defense against invading pathogens and maintaining sterility of the urinary tract. There are only a few publications regarding cathelicidin (LL-37) and a urinary tract infection (UTI). This study was done to investigate the plasma and urine levels of human LL-37 in patients with UTI. A case-control study was conducted at Omdurman Hospita…

  75. 140.

    Kozłowska E, Żelechowska P, Brzezińska-Błaszczyk E, Margulska A, et al. · Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2018 · PMID 29239826

    More and more data seems to imply that immune mechanisms are involved in the pathomechanism of bipolar disorder (BD). However, the primary role of cathelicidin LL-37 is defense against pathogens, more and more data indicated that this peptide strongly modulates immune system functioning and contributes to immune pathology of chronic and inflammatory diseases. No data is available on the level of LL-37 in bipolar patients. The aim of the study was to examine the circulating levels of cathelicidin…

  76. 141.

    Bei Y, Pan LL, Zhou Q, Zhao C, et al. · BMC medicine · 2019 · PMID 30782145

    Cathelicidins are a major group of natural antimicrobial peptides which play essential roles in regulating host defense and immunity. In addition to the antimicrobial and immunomodulatory activities, recent studies have reported the involvement of cathelicidins in cardiovascular diseases by regulating inflammatory response and microvascular dysfunction. However, the role of cathelicidins in myocardial apoptosis upon cardiac ischemia/reperfusion (I/R) injury remains largely unknown. CRAMP (cathel…

  77. 142.

    Tripathi S, Tecle T, Verma A, Crouch E, et al. · The Journal of general virology · 2013 · PMID 23052388

    LL-37, the only human cathelicidin, is a cationic antimicrobial peptide with antibacterial and antifungal activity. LL-37 is released from neutrophil granules and produced by epithelial cells. It has been implicated in host defence against influenza A virus (IAV) in recent studies. We now demonstrate dose-related neutralizing activity of LL-37 against several seasonal and mouse-adapted IAV strains. The ability of LL-37 to inhibit these IAV strains resulted mainly from direct effects on the virus…

  78. 143.

    Elgarhy LH, Ramadan BRR, Sallam FAA, Iskandarani DA, et al. · Archives of dermatological research · 2025 · PMID 39873762

    Vitiligo is a pigmentary disorder acquired and caused by the loss or destruction of melanocytes from the epidermis. There is strong proof that vitiligo is mainly an autoimmune disease. Cathelicidin (LL37), an antimicrobial polypeptide, is an important part of the innate immune system and has a role in different skin autoimmune diseases. The present work aimed to study the immunoexpression of cathelicidin in the vitiligo patients' skin to elucidate its possible role in vitiligo pathogenesis. Twen…

  79. 144.

    Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, et al. · The Journal of biological chemistry · 2008 · PMID 18765670

    Extracellular ATP, released at sites of inflammation or tissue damage, activates the P2X(7) receptor, which in turn triggers a range of responses also including cell proliferation. In this study the ability of the human cathelicidin LL-37 to stimulate fibroblast growth was inhibited by commonly used P2X(7) blockers. We investigated the structural requirements of the growth-promoting activity of LL-37 and found that it did not depend on helix sense (the all-d analog was active) but did require a…

  80. 145.

    Barlow PG, Beaumont PE, Cosseau C, Mackellar A, et al. · American journal of respiratory cell and molecular biology · 2010 · PMID 20097832

    Cationic host defense peptides are key, evolutionarily conserved components of the innate immune system. The human cathelicidin LL-37 is an important cationic host defense peptide up-regulated in infection and inflammation, specifically in the human lung, and was shown to enhance the pulmonary clearance of the opportunistic pathogen Pseudomonas aeruginosa in vivo by as yet undefined mechanisms. In addition to its direct microbicidal potential, LL-37 can modulate inflammation and immune mechanism…

  81. 146.

    Hu Z, Murakami T, Suzuki K, Tamura H, et al. · PloS one · 2014 · PMID 24454930

    Pyroptosis is a caspase-1 dependent cell death, associated with proinflammatory cytokine production, and is considered to play a crucial role in sepsis. Pyroptosis is induced by the two distinct stimuli, microbial PAMPs (pathogen associated molecular patterns) and endogenous DAMPs (damage associated molecular patterns). Importantly, cathelicidin-related AMPs (antimicrobial peptides) have a role in innate immune defense. Notably, human cathelicidin LL-37 exhibits the protective effect on the sept…

  82. 147.

    Lüthje P, Walker S, Kamolvit W, Mohanty S, et al. · Clinical and experimental immunology · 2019 · PMID 30216432

    Anti-microbial resistance increases among bacterial pathogens and new therapeutic avenues needs to be explored. Boosting innate immune mechanisms could be one attractive alternative in the defence against infectious diseases. The cholesterol-lowering drugs, statins, have been demonstrated to also affect the immune system. Here we investigate the effect of statins on the expression of the human cathelicidin anti-microbial peptide (CAMP) LL-37/hCAP-18 [encoded by the CAMP gene] and explore the und…

  83. 148.

    Li YX, Li BZ, Yan DZ · Molecular and cellular biochemistry · 2018 · PMID 29644526

    Dyslipidemia in patients with hypercholesterolemia has been recently linked to increased human cathelicidin LL-37 (LL-37) serum concentration. We tested a hypothesis that upregulated expression of LL-37 gene in peripheral blood leucocytes is involved in dyslipidemia in patients with hypercholesteremia. Patients with hypercholesterolemia were used in the study. Expression of LL-37 and human glyceraldehyde-3-phosphate dehydrogenase in peripheral blood leucocytes were quantified by real-time RT-PCR…

  84. 149.

    Porter RJ, Murray GI, Alnabulsi A, Humphries MP, et al. · The journal of pathology. Clinical research · 2021 · PMID 33988317

    Colorectal cancer (CRC) remains a leading cause of cancer mortality. Here, we define the colonic epithelial expression of cathelicidin (LL-37) in CRC. Cathelicidin exerts pleotropic effects including anti-microbial and immunoregulatory functions. Genetic knockout of cathelicidin led to increased size and number of colorectal tumours in the azoxymethane-induced murine model of CRC. We aimed to translate this to human disease. The expression of LL-37 in a large (n = 650) fully characterised cohort…

  85. 150.

    Schauber J, Iffland K, Frisch S, Kudlich T, et al. · Molecular immunology · 2004 · PMID 15261456

    Histone-deacetylase (HDAC) -inhibitors enhance acetylation of core proteins and this is linked to formation of transcriptionally active chromatin in various cells. In this study, the effect of HDAC inhibitors (butyrate, trichostatin A (TSA)) on the expression of the cathelicidin LL-37 in colon, gastric and hepatocellular cells was investigated. LL-37 expression was assessed in colon, gastric and hepatocellular cancer cells after treatment with HDAC-inhibitors. In parallel, histone H4 and HMGN2,…

  86. 151.

    Yanagisawa T, Ishii M, Takahashi M, Fujishima K, et al. · Molecular biology reports · 2020 · PMID 32886325

    LL-37, the only member of the cathelicidin family of cationic antimicrobial peptides in humans has been shown to exhibit a wide variety of biological actions in addition to its antimicrobial activity. However, the lymphangiogenic effect of LL-37 has not been elucidated yet. In this study, we examined the effects of LL-37 on lymphangiogenesis and evaluated the underlying molecular mechanisms. LL-37 treatment significantly increased the migration and tube-like formation of human dermal lymphatic m…

  87. 152.

    Alagarasu K, Patil PS, Shil P, Seervi M, et al. · Peptides · 2017 · PMID 28400226

    Human Cathelicidin antimicrobial peptide LL-37 is known to have antiviral activity against many viruses. In the present study, we investigated the in-vitro effect of LL-37 on dengue virus type 2 (DENV-2) infection and replication in Vero E6 cells. To study the effect of pretreatment of virus or cells with LL-37, the virus was pretreated with different concentrations of LL-37 (2.5μM-15μM) or scrambled (Scr) LL-37(5μM-15μM) and used for infection or the cells were first treated with LL-37 and infe…

  88. 153.

    Niyonsaba F, Iwabuchi K, Someya A, Hirata M, et al. · Immunology · 2002 · PMID 11972628

    The mast cell is one of the major effector cells in inflammatory reactions and can be found in most tissues throughout the body. During inflammation, an increase in the number of mast cells in the local milieu occurs, and such accumulation requires directed migration of this cell population. As it has previously been reported that the human cathelicidin-derived antibacterial peptide, LL-37, stimulates the degranulation of mast cells, we hypothesized that LL-37 could be a mast cell chemotaxin. Th…

  89. 154.

    Zhang Y, Jiang Y, Sun C, Wang Q, et al. · Biochemical and biophysical research communications · 2014 · PMID 24291709

    Airway mucus overproduction is a distinguishing feature of chronic obstructive pulmonary disease (COPD). LL-37 is the only member of human cathelicidins family of antimicrobial peptides and plays a central role in many immune and inflammatory reactions. Increasing evidence suggests the involvement of LL-37 in the pathogenesis of COPD. Here, we investigated the effects of LL-37 on airway mucus overproduction in COPD. We observed overexpression of both LL-37 and MUC5AC mucin (a major mucin compone…

  90. 155.

    Chow LN, Choi KY, Piyadasa H, Bossert M, et al. · Molecular immunology · 2014 · PMID 24091294

    Current therapies for autoimmune chronic inflammatory diseases e.g. rheumatoid arthritis (RA) include inhibitors of inflammatory cytokines. However, these therapies can result in increased risk of infections. There is a need to explore alternate strategies that can control inflammation without compromising the innate ability to resolve infections. In this study, we examined the effect of small peptides derived from endogenous cathelicidin peptides in a murine model of collagen-induced arthritis…

  91. 156.

    Liu Z, Wu J, Qin Z, Dong C, et al. · Antiviral research · 2022 · PMID 35038500

    Cathelicidins have been shown to effectively inhibit flavivirus replication in vitro. However, the effects of mouse and human endogenous cathelicidins on flavivirus infection in vivo are rarely known. We herein found that mouse endogenous cathelicidin CRAMP was significantly up-regulated upon Zika virus (ZIKV) infection. CRAMP deficiency markedly exacerbated ZIKV replication in testis, and aggravated ZIKV-induced testicular damage and spermatic damage in mice, indicating that endogenous cathelic…

  92. 157.

    Bąbolewska E, Brzezińska-Błaszczyk E · Cellular immunology · 2015 · PMID 25577339

    Cathelicidins, a family of antimicrobial peptides, are well known for their role in host defense, particularly against bacteria. Apart from direct killing of microbes through the membrane disruption, cathelicidins can also exert immunomodulatory effects on cells involved in inflammatory processes. Considering the important role of mast cells in inflammation, the aim of this study was to determine whether LL-37, human-derived cathelicidin, can induce mast cell activation. We have observed that LL…

  93. 158.

    Zielke C, Rad B, Nielsen JE, Li J, Pimcharoen S, Sawant M, Kamayirese S, Lin JS, Thiam HR, Barron AE. · 2026 · PMID 42156793

    The human cathelicidin host defense peptide LL-37 is expressed by many cell types, including neutrophils, macrophages, and epithelial cells, and forms complexes with nucleic acids that can have either beneficial or detrimental health effects. We suggest that these differential impacts are directly connected to the extent of nucleic acid binding by LL-37. Here, we use phage λ DNA and techniques such as high-resolution video microscopy, gel electrophoresis, circular dichroism, and displacement ass…

  94. 159.

    Giraldo-Lorza JM, Hernández Martínez SA, Sierra-Valdez FJ, Leidy C, Suesca E, Manrique-Moreno M. · 2026 · PMID 42134226

    The limited selectivity of antimicrobial peptides (AMPs) can lead to unintended damage to healthy eukaryotic cells, a process strongly influenced by membrane physicochemical properties. Cholesterol (CHO) is a key regulator of lipid packing, membrane order, and bilayer mechanical stability; however, its role in modulating AMP-membrane interactions remain incompletely understood. Here, we examine how CHO alters peptide-membrane interactions at the molecular level using eukaryotic membrane models c…

  95. 160.

    Pamuk C, Ersin N, Emingil G, Ozdemir G, Vural C, Vural C, Gül A, Çelik H, Gezgin Y. · 2026 · PMID 41656215

    <h4>Background</h4>Although caries is known to be influenced by diet and oral hygiene factors, susceptibility to the disease may be reduced by host factors, such as saliva antimicrobial peptides (AMPs). However, the relationship between salivary AMPs and early childhood caries (ECC) remains limited. Among the AMPs, cathelicidin LL-37 is mentioned in the literature for its bactericidal activity against oral pathogens, while statherin is recognized for its mechanism of reducing hydroxyapatite demi…

  96. 161.

    Jin X, Wang H, Tang H. · 2026 · PMID 41945358

    The host-defense peptide cathelicidin LL37 is an innate immune defense peptide with broad-spectrum antimicrobial effects. Experiments showed that the antimicrobial activity of LL37(17-29), the active core of LL37, was associated with peptide aggregation and fibrillization. Although wild-type (WT) LL37(17-29) aggregated into densely packed fibrils with strong antimicrobial activity, the F17S mutation exhibited a weaker antimicrobial effect, and I24K totally abolished the antimicrobial activity, w…

  97. 162.

    Guryanova SV, Belogurova-Ovchinnikova OY, Ovchinnikova TV. · 2026 · PMID 42042209

    The skin serves as the first line barrier of innate immunity, protecting the body from external influences and maintaining its homeostasis. Exogenous and endogenous stress factors alter the structure and functional properties of the skin. The search for compounds capable of counteracting these processes has allowed the identification of peptides as promising ingredients of products for medicinal and cosmetic applications. This review comprehensively examines the mechanisms of action and dermatol…

  98. 163.

    Łuckiewicz M, Wnorowska U, Zakrzewska M, Błażejczyk I, Daniluk T, Kondziołka W, Savage PB, Bucki R, Piktel E. · 2026 · PMID 41791569

    Wound healing and tissue regeneration are essential for maintaining skin integrity in the face of mechanical, chemical, or thermal damage. In adult mammals, the wound healing process may include complications leading to chronic wounds and hypertrophic scars. Recently, particular attention has been paid to governing wound healing using antimicrobial peptides (AMPs), such as human cathelicidin LL-37, and its synthetic analogs, ceragenins (CSAs). These substances are gaining interest due to their v…

  99. 164.

    Tamas V, Ulloa ER, Kumaraswamy M, Dahesh S, Zurich R, Nizet V, Coady A. · 2025 · PMID 41463786

    Urinary tract infections (UTIs) are common in children and are predominantly caused by uropathogenic <i>Escherichia coli</i> (UPEC). An increasing proportion of these strains produce extended-spectrum β-lactamases (ESBLs), which render β-lactam antibiotics ineffective. Interestingly, some patients with ESBL-producing UTIs improve clinically following treatment with antibiotics like cephalexin, despite demonstrated in vitro resistance. Working alongside and at times synergistically with antibioti…

  100. 165.

    Nourizadeh M, Ghahari AA, Zandi E, Rasouli SZ, Davari S, Hoseinzadeh M, Nourazar MA. · 2026 · PMID 41493387

    Cathelicidins are evolutionarily conserved host defence peptides known for their dual antimicrobial and immunomodulatory functions. Among them, LL-37 in humans and CRAMP in rodents have emerged as crucial regulators of both mucosal immunity and CNS inflammation. This review explores the emerging evidence that positions cathelicidins as key modulators of the gut-brain axis, a bidirectional communication network increasingly implicated in neuroinflammatory and neurodegenerative disorders. Drawing…

  101. 166.

    Soman D, P J, Cm M, Radhakrishnan R. · 2026 · PMID 41544412

    <h4>Background</h4>Antimicrobial peptides are integral components of the innate immune system and play a vital role in maintaining oral homeostasis. LL-37, the only human cathelicidin antimicrobial peptide, has gained increasing attention due to its broad-spectrum antimicrobial activity and diverse immunomodulatory functions within the oral cavity.<h4>Objective</h4>This narrative review aims to characterise the molecular structure, biological functions, and clinical relevance of LL-37 in oral he…

  102. 167.

    Taniguchi M, Taruya A, Kitahara C, Ota S, Kato T, Desaki Y, Sasaki I, Katayama Y, Wada T, Takahata M, Satogami K, Ozaki Y, Kashiwagi M, Shiono Y, Honda K, Yamano T, Takemoto K, Kuroi A, Kitabata H, Hemmi H, Matsuoka T, Nishimura Y, Tanaka A. · 2026 · PMID 41905956

    <h4>Background</h4>Visceral fat (VF), particularly epicardial adipose tissue (EAT), plays a crucial role in the development of coronary artery disease (CAD). Cathelicidin (LL37) is an antimicrobial peptide involved in innate immunity and has been implicated in inflammatory processes. However, the relationship between VF accumulation, cathelicidin, and atherosclerosis remains unclear.<h4>Methods and results</h4>Seventy-eight subjects without CAD were enrolled and classified by obesity type: norma…

  103. 168.

    Gonzalez SM, Aguilar-Jimenez W, Rugeles MT, Siddik AB, Labossiere EH, Ball TB, Su RC. · 2026 · PMID 42079659

    <h4>Introduction</h4>Elevated levels of serum Vitamin D (VitD) and increased expression of its receptor on peripheral blood cells have been reported in individuals who have been exposed to HIV-1 yet remain seronegative (HESN). This study aimed to investigate the potential antiviral role of VitD in the female genital epithelium, which constitutes the first physical barrier against HIV-1. We hypothesized that VitD may modulate susceptibility to HIV-1 infection by influencing epithelial functions s…

  104. 169.

    Wang H, Zhou C. · 2025 · PMID 41646975

    Rosacea is a chronic inflammatory cutaneous disorder predominantly affecting the centrofacial region, whose pathogenesis is complex and not yet fully understood. In this review we summarized the latest significant advances in the pathogenesis of rosacea in recent years. In genomic studies, the application of bioinformatics techniques such as whole-genome sequencing has identified novel susceptibility genes and linked multiple pathogenic mechanisms. Neurovascular dysfunction resulting from abnorm…

  105. 170.

    He X, Zhang Y, Lou J, Wu J, Xu S, Zhu G, Tang J, Fang Y, Cao J. · 2026 · PMID 41843625

    Malaria control is challenged by the emergence of resistance to virtually all antimalarial drugs, from the frontline artemisinin to other classes, highlighting the critical need for new therapies. This study demonstrates that the human antimicrobial peptide LL-37 exhibits antiplasmodial activity against both drug-sensitive and drug-resistant parasites in vitro. LL-37 selectively targets infected red blood cells through membrane disruption mediated by phosphatidylserine externalization and choles…

  106. 171.

    Bhusal A, Lee WH, Suk K. · 2026 · PMID 41487016

    <h4>Background</h4>Antimicrobial peptides/proteins (AMPs), also termed host defense peptides, are well-known effector molecules in innate immunity across all organisms. Recent research has revealed that AMPs possess multifunctional properties beyond their antimicrobial activity, including roles in neuroinflammation. The expression of AMPs has been detected within the central nervous system (CNS) at a basal level and is generally upregulated in various neurological disorders. Owing to its express…

  107. 172.

    Pinheiro da Silva F, Soriano FG, Hajjar LA. · 2026 · PMID 42011032

    <h4>Introduction</h4>Antimicrobial peptides (AMPs) are essential components of the innate immune system, exhibiting diverse mechanisms of action.<h4>Objective</h4>This study investigates the roles of cathelicidin (LL-37), alpha-defensins, and the S100 proteins S100A8 and S100A9 in systemic inflammation associated with sepsis, severe COVID-19, and acute pancreatitis using whole-blood bulk RNA-sequencing data.<h4>Results</h4>Gene co-expression network analysis revealed that during septic shock and…

  108. 173.

    Dhaffouli F, Elloumi N, Sellami K, Bahloul E, Tahri S, Turki H, Hachicha H, Abida O. · 2026 · PMID 41544316

  109. 174.

    Fang Y, Zhang Z, Cao Q, Li Y, Duan Y, Meng P, Duan Z, Wang G, Gao J, Hua M, Huang B, Zhou T, Zhang H, Kong F, Zhang Y, Li M, Ma ZS, Li Y, Wang Z, Cheng R, Lu Q, Ni H, Lai R. · 2026 · PMID 41953980

    <h4>Background</h4>ApoB (apolipoprotein B)-containing lipoproteins are causal risk factors for atherosclerotic coronary artery disease (CAD). Since LL-37 (human cathelicidin peptide) binds to ApoB-100 in this pathological context, we investigated whether the circulating LL-37-ApoB-100 complex could serve as a biomarker for CAD.<h4>Methods</h4>We performed surface plasmon resonance and protein-protein docking to demonstrate the direct LL-37-ApoB-100 interaction. We developed a specific polyclonal…

  110. 175.

    Tan YL, Cavalcante P, Cirone KM, Tran J, Fiorani F, Young D, Dufour A, Finney C, Cobo ER. · 2026 · PMID 41728969

    Toxoplasmosis, a disease caused by apicomplexan <i>Toxoplasma gondii (Tg)</i>, is associated with various neuropsychiatric and behavioral conditions. Toxoplasmosis can cause serious complications for those with weakened immune systems and during pregnancy. Cathelicidins, peptides with antimicrobial and immunomodulatory functions, are critical factors in host defense against microbes, but their role in parasitic infections is less well understood. This study demonstrates the protective function o…

  111. 176.

    Barron AE, Lin JS, Ryder MI, Bergman P. · 2026 · PMID 41424314

    The etiology of Alzheimer's disease (AD) remains under active debate. In this perspective, we explore the hypothesis that a primarily infection-caused chronic dysregulation and weakening of human innate immunity via the underexpression, degradation, and inactivation of innate immune proteins necessary for direct antimicrobial effects and regulation of host defense and autophagy could lead to AD. Key evidence relates to the fact that important innate immune proteins such as LL-37-which can bind A…

  112. 177.

    Aguilar-Ruiz S, Sánchez-Peña F, Rodríguez-Magadán H, Domínguez-Martínez M, Bernardino-Hernández H, Aquino-Domínguez A. · 2026

  113. 178.

    Grzywacz D, Nuti F, Żamojć K, Samsonov SA, Malinowska M, Paduszyńska M, Papini AM, Makowska J. · 2026 · PMID 41780202

    Glycosylation represents a versatile strategy in peptide glycoengineering to modulate the structural, physicochemical, and biological properties of antimicrobial peptides (AMPs). In this study, we report the synthesis and characterization of O- and N-glycosylated analogues of the C-terminal fragment of human cathelicidin LL-37 (Ac-DFLRNLVPRTES-COOH), achieved via solid-phase peptide synthesis using Fmoc-Thr(β-d-Glc) and Fmoc-Asn(β-d-Glc) as glycosylated building blocks. The metal-binding affinit…

  114. 179.

    Wang Y, Zhou S, Su D, Song Z, Chen Y, Mwangi J, Lv Q, Wang A, Lai R. · 2026 · PMID 41932495

    <h4>Introduction</h4>Antimicrobial peptides (AMPs) hold promises to counter antimicrobial resistance. They cause several deleterious effects in bacterial cells by interfering with cell wall biosynthesis, DNA replication, transcription, and translation.<h4>Objectives</h4>The essential role of cellular respiration in bacterial survival underscores its potential as a target for antimicrobial intervention. However, few studies have explored if and how AMPs target bacterial respiratory terminal oxida…

  115. 180.

    Zhang P, Ye Z, Dou H, Li S, Jiao X, Wang Y. · 2026 · PMID 41506548

    Cathelicidins are crucial antimicrobial peptides (AMPs) that play a key role in the innate immunity of marine vertebrates. The pygmy sperm whale (Kogia breviceps), which resides in environments populated by diverse microbial communities, faces complex pathogenic threats; however, its cathelicidin family AMPs remain uncharacterized. In this study, we identified three novel cathelicidin peptides-Kb4-1, Kb4-2, and Kb5 from the whale (Kogia breviceps). All three peptides exhibited broad-spectrum and…

  116. 181.

    Kodori M, Farhadi N, Jafari GA, Afkhami H, Yousefi MH. · 2026 · PMID 41622193

    Extensive research has investigated the therapeutic potential of mesenchymal stem cells (MSCs) in treating infectious diseases and mitigating tissue damage caused by these diseases. MSCs, along with their exosomes, present a promising avenue for combating infectious diseases, particularly HACEK endocarditis (HE). MSCs possess immunomodulatory properties and aid in tissue repair, while exosomes carry bioactive molecules. Antimicrobial peptides (AMPs) released by MSCs demonstrate efficacy against…

  117. 182.

    Wattayagorn V, Mansuwan T, Angkanawin K, Sapkaew C, Sinthuvanich C, Watthanasakphuban N, Chumnanpuen P. · 2025 · PMID 41155367

    The development of anticancer peptides (ACPs) has emerged as a promising strategy in targeted cancer therapy due to their high specificity and therapeutic potential. Cathelicidin-derived antimicrobial peptides represent a particularly attractive class of ACPs, yet systematic evaluation of their anticancer activity remains limited. In this study, we conducted virtual screening of eight cathelicidin-derived peptides (AL-38, LL-37, RK-31, KS-30, KR-20, FK-16, FK-13, and KR-12) to assess their poten…

  118. 183.

    Li X, Zhang M, Xu Z, Li Y, Bian S, Tang Y, Jiao X, Gundogdu O, Huang J. · 2026 · PMID 42160414

    <i>Campylobacter jejuni</i> (<i>C. jejuni</i>) is a leading cause of human gastroenteritis worldwide and must overcome intestinal innate immunity, including antimicrobial peptide LL-37. However, how <i>C. jejuni</i> responds to LL-37 remains unclear. Here, we showed that <i>C. jejuni</i> infection stimulates intestinal epithelial cells to secrete LL-37, exhibiting effective antibacterial activity against 86.3% of <i>C. jejuni</i> clinical isolates by disrupting essential processes required for b…

  119. 184.

    Alfaki DA, Elbasheir MM. · 2025 · PMID 41351171

    Plasmodium-induced malaria infection remains a leading global health threat. Host defense peptides (HDPs), key components of innate immunity, target multiple stages of Plasmodium development through direct antimicrobial activity and immunomodulation. These peptides represent promising agents as antimalarial compounds due to their dual role in directly targeting Plasmodium parasites and modulating host immune responses. Several HDPs, including defensins, cathelicidins, NK-2 peptide, platelet fact…

  120. 185.

    Ba Q, Yao J, Tian H, Meng Y, Kong Y, Jia Y, Xu Z, Yin S, Gong W, Wang Y, Yang Y, Gao C, Yang M. · 2026 · PMID 41653943

    Effective management of infected skin wounds remains a major clinical challenge, particularly as rising antibiotic resistance compromises conventional therapies. Antimicrobial peptides (AMPs) have emerged as promising alternatives, but their clinical translation is hindered by poor stability and potential toxicity. In this study, we report the rational design of a novel antimicrobial peptide, FR-20, a self-assembling derivative of the human cathelicidin LL-37, engineered for enhanced structural…

  121. 186.

    Zhang J, Hou Y, Yasuda T, Chow SYA, Ito S, Otsuka M, Ikeuchi Y, Li X, Sugihara K. · 2026 · PMID 41889757

    Synergistic bactericidal effects between antimicrobial peptides (AMPs) have been widely studied, yet their cooperative roles in reducing host-cell cytotoxicity remain poorly understood. Inspired by the cross-seeding observed in α-synuclein and β-amyloid fibril formation, we report that the cooperative reduction of cytotoxicity by two major AMPs, human cathelicidin (LL-37) and human α-defensin-1 (HNP-1), is governed by their heteroaggregation states. Through the integration of dynamic light scatt…

  122. 187.

    Hayashida K, Esko JD, Gallo RD, Liu J, Kao WW, Park PW. · 2025 · PMID 41551642

    Cathelicidins are short cationic peptides with potent microbicidal activities and comprise an important arm of host innate immunity. Many cell types can produce cathelicidins, but they are mainly expressed by recruited immune cells and are induced in epithelial cells during infection. Although the mechanisms of bacterial killing by cathelicidins have been largely elucidated in vitro, those that regulate their activities in vivo are less well understood. Bacterial pathogens often co-opt host extr…

  123. 188.

    Ansari AW, Habib T, Ahmad F, Raheed T, Elizabeth CS, Al-Harami S, Jochebeth A, Steinhoff M. · 2026 · PMID 40835085

    Rosacea is a chronic inflammatory disease of facial skin with unknown pathophysiology. Abnormal overexpression of human antimicrobial peptide LL-37 is a hallmark of rosacea. However, its significance in rosacea pathogenesis is not fully understood. We sought to understand the molecular mechanisms of LL-37-mediated rosacea-like inflammation in an in vitro model of normal human epidermal keratinocytes. Transcriptome profiling of LL-37-treated keratinocytes identified signatures of IFN-stimulating…

  124. 189.

    Zhang J, Zhang H, Chen Y, Liu H, Peng S, Zhao J, Luan Z, Zhang Y, Dong M, Jin W, Sun G. · 2026 · PMID 42043231

    LL-37, a 37-amino acid human-derived antimicrobial peptide, was shown in our earlier clinical study to shorten the negative conversion time of the Omicron BA.5.1.3 variant of SARS-CoV-2. In this work, we investigated the broad mechanism of LL-37 by examining its inhibitory effect on non-enveloped virus <i>Enterovirus 71</i> (EV71). LL-37 treatment dose-dependently reduced EV71 viral RNA abundance, suppressed virus-encoded protein expression, and decreased infectious titers, acting predominantly…

  125. 190.

    Chen Z, Fan X, Zhou L, Zou L, Wan L, Li Y, Li C, Kuai L, Cai J, Zhang L, Li Y, Li H, Wan K, Liu H, Xu H, Xiao F. · 2026 · PMID 41632588

    Current anti-tuberculosis treatments primarily target extracellular <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), but exhibit limited efficacy against intracellular <i>Mtb</i>, leading to incomplete clearance of pathogens and an increased risk of recurrence. Antimicrobial peptides (AMPs) possess broad-spectrum antimicrobial activity and low potential for resistance development. Here we developed an <i>in vitro</i> mRNA expression platform which not only facilitates intracellular AMPs expressio…

  126. 191.

    Keshavarz S, Hirschfeld J, Grant MM. · 2026 · PMID 42131197

    <h4>Introduction</h4>Periodontitis is a plaque-induced condition that causes irreparable damage to the supporting tissues of the teeth, and tobacco smoking is a recognized exacerbating and risk factor. Antibiotic-resistant bacteria are a consequence of antibiotic overuse. Antimicrobial peptides (AMPs) are innate immune system molecules that show promise in combating antibiotic resistance.<h4>Methods</h4>The current work investigated the efficiency of two synthetic derivatives of AMP human cathel…

  127. 192.

    Asmamaw D, Cai H, Prateeksha P, Khalid M, Mwangi J, Yi W, Lu Q, Lai R, Duan Z. · 2026 · PMID 41485275

    The increasing prevalence of multidrug-resistant (MDR) bacterial infections poses global health challenges, highlighting the urgent need for new antimicrobial agents. The key advantages of antimicrobial peptides are their ability to rapid bactericidal activity and their low propensity for resistance development. In this study, we designed a series of antimicrobial peptides by fusing the two fragments of antimicrobial peptides Cathelicidin-BF (1-9) and LL-37 (17-29), and then tested against selec…

  128. 193.

    Włodarczyk J, Kamysz E, Fichna J. · 2025 · PMID 41091413

    <h4>Background</h4>Colorectal cancer (CRC) remains a major global health challenge, with increasing incidence, particularly among individuals under 50 years of age. Cathelicidin LL-37, a multifunctional antimicrobial peptide, has shown promise in cancer treatment, particularly for its anti-inflammatory effects.<h4>Methods</h4>Using in vitro and in vivo models, we investigated the anticancer potential of KR-12 amide, the shortest active fragment of LL-37, and its short-chain fatty acid (SCFA)-mod…

  129. 194.

    Ramírez-Ledesma MG, Ávila EE, Alva-Murillo N. · 2026 · PMID 41683391

    Trichomoniasis is the most prevalent non-viral sexually transmitted infection worldwide and is caused by <i>Trichomonas vaginalis</i>. The development of resistance against the standard treatment, metronidazole, highlights the need for alternative therapeutic approaches. The role of innate immune cells is crucial for understanding trichomoniasis; however, the contribution of monocytes remains poorly characterized. We previously reported that the antimicrobial peptides LL-37 and its derivative KR…

  130. 195.

    Deng E, Pei Y, Yuan K, Yang J, Cao SA, Yang X, Li G, Liang L, Jin L, Zhu T. · 2026 · PMID 41948036

    [This corrects the article DOI: 10.3389/fmicb.2026.1770133.].

  131. 196.

    Zhu M, Yang Y, Huang B, Huang W. · 2025

    Cathelicidins are a family of cationic antimicrobial peptides that play a critical role in innate immune defense. Like other antimicrobial peptides, cathelicidins can effectively kill pathogens while minimizing the risk of promoting antimicrobial resistance, a growing concern in the aquaculture. Although cathelicidins are widely distributed across vertebrates, from basal vertebrate species such as hagfish and lampreys to mammals, the number of identified cathelicidin sequences in fish remains re…

  132. 197.

    Yan H, Wang Y, He X, Li Y, Yang L, Yang J, Meng X, Peng C, Zhang X, Yakupu A, Wen Y, He Q, Qahar M. · 2026 · PMID 41972150

    Chronically infected wounds continue to pose a major challenge in clinical practice. Their persistence reflects the convergence of sustained microbial colonization, inappropriate or prolonged immune activation, and insufficient tissue regenerative capacity, which together establish a self-reinforcing pathological environment. In routine clinical management, approaches centered on debridement and antimicrobial therapy often fail to achieve durable healing, indicating that key regulatory mechanism…

  133. 198.

    Ghosh K, Dasgupta P, Kanaujia SP. · 2026 · PMID 41951073

    Non-typeable Haemophilus influenzae (NTHi) is an opportunistic pathogen that causes several respiratory diseases. It employs the Sap (sensitivity to antimicrobial peptide) transporter to achieve resistance against the human antimicrobial peptides (hAMPs). In H. influenzae, the Sap system comprises six subunits, SapABCDFZ, akin to the canonical ATP-binding cassette (ABC) importers. The subunit HiSapA, which plays a role in the substrate binding, has been reported to capture hAMPs such as LL-37 an…

  134. 199.

    Shibagaki M, Chrisnanto JO, Tefera DA, Kumeta H, et al. · International journal of biological macromolecules · 2026 · PMID 42727664

    The human cathelicidin LL-37 is a widely studied 37-residue antimicrobial peptide with diverse biological functions. However, its strong aggregation propensity hinders the efficient recombinant production of this peptide. Previously reported expression strategies often face limitations such as low solubility, inefficient tag removal, and/or the need for detergents, which complicate downstream sample preparation. Here, we developed a detergent-free method for producing recombinant LL-37 in Escher…

  135. 200.

    Pan W, Tian C, Ding Y, Pei Z, et al. · International journal of biological macromolecules · 2026 · PMID 42669340

    The antimicrobial peptide LL-37 holds considerable therapeutic potential for treating infection and inflammation; however, its clinical application is often limited by poor stability, susceptibility to proteolytic degradation, and insufficient targeting capability. In this study, we engineered a targeted fusion protein (designated as FL) based on ferritin light chain (FTL) by genetically fusing the LL-37 peptide to the C-terminus of FTL, thereby markedly enhancing the structural stability and pr…

  136. 201.

    Wei L, Wang L, Zhong F, Wang F, et al. · Cytokine · 2026 · PMID 42641316

    Diabetic wounds pose a significant therapeutic challenge. While the antimicrobial peptide LL-37 and adipose-derived stem cells (ADSCs) individually show potential for wound repair, the efficacy and mechanism of their combined treatment remain unclear. This study aimed to investigate the therapeutic effect of LL-37 combined with ADSCs on diabetic wound healing. Clinical samples from diabetic and non-diabetic patients were analyzed, combined with bioinformatics analysis of public datasets (GSE1444…

  137. 202.

    Shahbaz M, Al-Maleki AR, Cheah CW, Aziz J, et al. · Journal of periodontology · 2026 · PMID 42937026

    Porphyromonas gingivalis peptidyl-arginine deiminase (PPAD) enzyme has been implicated in rheumatoid arthritis (RA) pathogenesis through protein citrullination and its potential contribution to neutrophil-associated inflammatory responses and anti-citrullinated protein antibody (ACPA) autoimmunity. However, its role in early stages of RA remains unclear. This study investigated the association of PPAD with citrullinated histone H3 (CitH3), cathelicidin (LL-37), and ACPA in preclinical RA (preRA)…

  138. 203.

    Ejikemeuwa A, He J, Wang Y, Li G, et al. · bioRxiv : the preprint server for biology · 2026 · PMID 42995944

    Circulating cell-free DNA in inflamed tissues contains different forms of DNA, including extrachromosomal circular DNA (eccDNA). The role of DNA topology in innate immune sensing remains poorly understood. Here we show that circular DNA is a potent ligand for human plasmacytoid dendritic cells (pDCs) and that the cathelicidin host defense peptide LL37 selectively enhances circular DNA-induced activation. Across eccDNA, minicircle and synthetic circular DNA species, LL37 strikingly amplified type…

  139. 204.

    Feng C, Zhang H, Wang P, Zhang L, et al. · International immunopharmacology · 2026 · PMID 42420052

    The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.intimp.2026.117081. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies-and-standards/article-withdrawal.

  140. 205.

    Jiang L, Yang F, Wu J, Li Z, et al. · Veterinary research · 2026 · PMID 42839251

    Host defense peptides (HDPs) possess both direct bacteriocidal and immunomodulatory activities. In this study, chicken cathelicidin-1 (cCATH-1) and chicken cathelicidin-3 (cCATH-3) were selected based on their markedly different minimum inhibitory concentrations (MICs) against avian pathogenic Escherichia coli (APEC) strains, with MICs of cCATH-1 being 4- to 16-fold lower than those of cCATH-3. However, following intraperitoneal challenge with APEC strain E058 (4 × 10⁶ CFU/mouse), 80% of cCATH-3…

  141. 206.

    Francis F, Verma SS, Hans A, Chaudhary N · Archives of biochemistry and biophysics · 2026 · PMID 42462895

    Cathelicidin-DM is a host defence peptide isolated from the Asian common toad Duttaphrynus melanostictus. The peptide has been reported in the literature to exhibit antibacterial and wound-healing activities. The mechanism of antimicrobial activity, however, remains unclear. As most cathelicidins reported in the literature exhibit their antimicrobial activity through membrane perturbation, we investigated cathelicidin-DM's interfacial and membrane binding activities using molecular dynamics simu…

  142. 207.

    Khamlaiwong P, Karnmongkol C, Musigapan R, Wiriyaampaiwong P, et al. · Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2026 · PMID 42413799

    Amphibians have evolved sophisticated innate immune mechanisms shaped by dual aquatic-terrestrial lifestyles, yet the pulmonary cathelicidin repertoire remains incompletely characterized. This study investigated the diversity, and comparative activity profiles of lung-expressed cathelicidin in the tiger frog (Hoplobatrachus rugulosus) through an integrated transcriptomic and biochemical approach. RNA sequencing of lung tissue identified four cathelicidin paralogs-Hr-CATH1 to Hr-CATH4 (AS34, SN34…

  143. 208.
  144. 209.

    Fuertes-Chaves C, Gonzalez JE, Suesca E, Guzmán-Sastoque P, et al. · Biochimica et biophysica acta. Biomembranes · 2026 · PMID 42303202

    Staphylococcus aureus (S. aureus) is an opportunistic pathogen that is a global health concern for its ability to cause a wide spectrum of clinical infections ranging from minor skin abscesses to systemic conditions such as sepsis and pneumonia. Due to the emergence of resistance to commonly used antibiotics, there has been interest in exploring the use of antimicrobial peptides to treat S. aureus infections. However, changes in the lipid composition of the lipid bilayer membrane can alter the a…

  145. 210.

    Nguyen T, Yahara Y, Shimada E, Puviindran V, et al. · bioRxiv : the preprint server for biology · 2026 · PMID 42856300

    The pace of fracture repair declines with age, increasing the risk of delayed union and nonunion. Delayed union and nonunion are associated with significant morbidity and even mortality with few effective non-surgical interventions. Here, we identify cathelicidin antimicrobial peptide (CAMP) as an age-dependent regulator of bone repair. Single-cell RNA sequencing and immunohistochemistry demonstrated higher CAMP expression during fracture healing in young compared with aged mice. Global or myelo…

  146. 211.

    Szarszoń K, Luszawska M, Jewgiński M, Janek T, et al. · Dalton transactions (Cambridge, England : 2003) · 2026 · PMID 42708248

    Human cathelicidin LL-37 is an antimicrobial peptide naturally present in saliva that plays an important role in host defence against bacterial and fungal pathogens. Although LL-37 is known to bind Cu(II) and Zn(II) ions, the corresponding coordination modes have remained unresolved. Here, the metal-binding properties, conformational features and biological activity of LL-37, its C-terminal fragment DF-12, and the corresponding all-D analogue df-12 were investigated using potentiometric, spectro…

  147. 212.

    Luo H, Li S, Du H, Yang W, et al. · Histology and histopathology · 2026 · PMID 42745581

    Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, often diagnosed at advanced stages with limited therapeutic options. Cathelicidin LL-37, an antimicrobial peptide, has demonstrated context-dependent roles in cancer progression. This study aimed to elucidate the function and underlying mechanism of LL-37 in GC, with a focus on angiogenesis and metastasis. The effects of LL-37 were investigated in GC cell lines (HGC27, MKN74, AGS, HSC-39, NCI-N87) and mouse models…

  148. 213.

    Han W, Watkins NJ, Camesano TA · Biomolecules · 2026 · PMID 42793156

  149. 214.

    Yamaguchi T, Hosokawa K, Mineta T, Hosokawa R, et al. · PloS one · 2026 · PMID 42685028

    Obstructive sleep apnea (OSA) is characterized by systemic inflammation, intermittent hypoxemia, and immune dysregulation and has been associated with increased susceptibility to viral infections. In this study, we aimed to evaluate plasma concentrations of the antimicrobial peptide cathelicidin LL-37 (pLL-37) in individuals with OSA. The associations between pLL-37 levels, demographic characteristics, and polysomnographic (PSG) parameters were assessed in 58 individuals with OSA and 20 healthy…

  150. 215.

    Ratcliffe P, Löfstedt AH, Sundin M, Höglund P · British journal of haematology · 2026 · PMID 42644563

    Autoimmune neutropenia (AIN) in early childhood is caused by autoantibodies targeting neutrophil surface antigens, most commonly CD16 (FCGR3B), and must be distinguished from congenital neutropenia, malignancy-associated neutropenia and chronic idiopathic neutropenia (CIN). In this study, the diagnostic performance of the cell-based granulocyte agglutination test (GAT) and granulocyte immunofluorescence test (GIFT) was compared with the bead-based LabScreen Multi (LSM) assay in 214-suspected AIN…

  151. 216.

    Guerra S, Qu C, LaRock CN · bioRxiv : the preprint server for biology · 2026 · PMID 42812144

    Cathelicidins are a class of antimicrobial peptides (AMPs) that are part of the first line of defense of the innate immune system. While cathelicidin-derived peptides such as LL-37 can be directly bactericidal,

  152. 217.

    Sun Q, Peng G, Wu Z, Cui L, et al. · Cell reports · 2026 · PMID 42593966

    Melanoma progression is regulated by not only tumor-intrinsic factors but also dynamic crosstalk with the surrounding epidermis. Here, we observed spatial suppression of cathelicidin LL-37 in tumor-adjacent epidermis compared with that in distal regions in clinical specimens. We further found that melanoma-derived exosomes suppressed keratinocyte LL-37 expression, which was driven in part by exosomal hsa-miR-221-5p through impaired sustained EGFR signaling. Functionally, keratinocyte-derived LL-…

  153. 218.

    Lu F, Liu Z, Jiang H, Zheng H, et al. · Journal of bone oncology · 2026 · PMID 42388271

    Osteosarcoma (OS) is an aggressive primary bone malignancy with poor prognosis for metastatic and recurrent cases, highlighting an urgent need for novel therapeutic strategies. The human cathelicidin peptide LL-37 exerts context-dependent anti-tumor effects, yet its functional role in OS remains largely undefined. This study aimed to explore the anti-OS activity and underlying mechanisms of LL-37. In vitro experiments were performed using OS cell lines and normal human bone marrow mesenchymal st…

  154. 219.
  155. 220.

    Rayan B, Barnea E, Indig R, Pantoja CF, et al. · eLife · 2026 · PMID 42474037

    Amyloid-forming peptides are increasingly recognized as dynamic regulators at the host-pathogen interface, yet how environmental factors control their assembly and activity remains poorly understood. Here, RNA acts as a concentration-dependent regulator of two sequence-related α-helical peptides with fundamentally different assembly behaviors: the cross-α amyloid-forming

  156. 221.

    Byun KA, Park JY, Oh S, Shin JY, et al. · International journal of molecular sciences · 2026 · PMID 42511767

    Rosacea is a chronic inflammatory skin disorder driven by dysregulated cathelicidin processing and excessive LL-37, which triggers a circuit involving Toll-like receptor 2 (TLR2)/kallikrein-5 (KLK5)-dependent amplification and downstream mechanistic target of rapamycin complex 1 (mTORC1), NF-κB, and NLR family pyrin domain containing 3 (NLRP3) inflammasome pathways. We hypothesized that poly-D,L-lactic acid (PDLLA) could attenuate this inflammatory cascade by inducing macrophage-derived interleu…

  157. 222.

    Fu Q, Xie K, Yu B, Huang Z, et al. · BMC veterinary research · 2026 · PMID 42458433

    Cathelicidins are short cationic peptides secreted in pro-peptide, characterized by a conserved N-terminal cathelin domain and a diverse C-terminal mature peptide. While the antimicrobial and immunomodulatory properties of mature cathelicidins are well-characterized, whether their precursor forms (pro-forms) possess biological activity remains a subject of debate. Amid the global challenge of antimicrobial resistance (AMR) and the mandate to reduce antibiotic use in livestock, cathelicidins repr…

  158. 223.

    Ravichandran T, B G H, Ganesan N, K SG · Bioinformation · 2026 · PMID 42701697

    Oral squamous cell carcinoma (OSCC) is the predominant form of oral malignancy, with late-stage diagnosis contributing to poor prognosis. Oral potentially malignant disorders (OPMDs) often precede OSCC, underscoring the need for early diagnostic biomarkers. Hence, salivary cathelicidin LL-37 levels were quantified using ELISA in 80 participants. Participants were divided into four groups: OSCC, tobacco- associated OPMDs, non-tobacco-associated OPMDs, and healthy controls. Salivary cathelicidin L…

  159. 224.

    Mao J, Li X, Liao K, Liu L, et al. · Regenerative biomaterials · 2026 · PMID 42445046

    Gingival recession exposes the roots, leads to dentin hypersensitivity, and heightens the progression of periodontitis, and poses a threat to oral health and appearance. Conventional treatment uses autogenous palatal grafts, requiring a second surgical site and adding patient discomfort. To overcome autograft limitations, this study developed a hydrogel scaffold as a potential biomaterial candidate for gingival soft tissue augmentation. We developed a multifunctional HA/SF hydrogel scaffold by i…

  160. 225.

    Eren G, Turkoglu O, Cetinkalp Ş, Atmaca H, et al. · European oral research · 2026 · PMID 42388571

    To determine whether low serum vitamin D levels are inversely correlated with clinical parameters and positively correlated with gingival crevicular fluid (GCF) 25(OH)D Twenty-six well-controlled T2DM patients with periodontitis and Vitamin D insufficiency (Vit.D-IS group), and 15 well-controlled T2DM patients with periodontitis and Vitamin D sufficiency (Vit.D-S group) were included. Papilla bleeding index, bleeding on probing (BOP), supragingival plaque, clinical attachment level (CAL) and pro…

  161. 226.

    Xu M, Chan CPS, Cong L, Chung JPW, et al. · Reproduction & fertility · 2026 · PMID 42246964

    Birth control and sexually transmitted infections are global concerns. Nonoxynol-9 (N-9) is the most commonly used component in spermicides, with controversial safety and efficacy. LL-37 has been considered the most promising antimicrobial peptide for developing spermicides. Thus, we aimed to refine the regime of N-9 through the adjunction of LL-37 with higher spermicidal efficacy, safety, and antimicrobial activity. Processed sperm from density gradient centrifugation were treated with nonoxyno…

  162. 227.

    Dimayuga PC, Zhou J, Zhao X, Chyu KY, et al. · Physiological reports · 2026 · PMID 42304820

    Elevated LL-37 IgG levels are implicated in inflammatory conditions and immune complexes formed with LL-37 potentially propagate immunothrombosis in acute coronary syndrome (ACS). The reported binding of LL-37 to LDL may be relevant in this context given that LDL autoantibodies are implicated in ACS risk. In this report, three distinct cohorts were used to evaluate immunologic characteristics, clinical relevance, and potential mechanisms of elevated LL-37 IgG levels in ACS. First, evaluation of…

  163. 228.

    Yoon D, Lee JO, Jang YN, Yoo KH, et al. · Annals of dermatology · 2026 · PMID 42244277

    Rosacea is a chronic inflammatory disorder characterized by flushing, erythema, papules/pustules, and telangiectasia. Several clinical studies have investigated the efficacy of botulinum neurotoxin A (BoNT/A) in the treatment of rosacea, but its mechanism of action remains unclear. This study aims to examine the potential role of BoNT/A in a mouse model of rosacea-like skin lesions induced by the 37-amino acid C-terminal cathelicidin peptide (LL-37). Mice were randomly divided into 4 groups: Con…

  164. 229.

    Liao H, Lai S, Wang K, Chai J, et al. · Zoological research · 2026 · PMID 42267565

    Cathelicidins are central effectors of innate host immunity against invading microorganisms and represent a promising source of next-generation anti-infective agents. However, current understanding of both antimicrobial activity and immunomodulatory function within this peptide family remains incomplete. In the present study, a novel cathelicidin peptide, designated HR-CATH2, was identified from the skin of the Chinese tiger frog (

  165. 230.

    Bagnicka E, Szprynca A, Kościuczuk E, Jarczak J, et al. · Frontiers in immunology · 2026 · PMID 42220501

    The bovine mammary gland employs epithelial defenses against bacterial invasion, including a bilayer columnar epithelium lining the lactiferous sinuses and mucosal folds at the inner end of the teat canal. The aim of this The expression of selected genes was analyzed using RT-qPCR. Followed by: 'TATA box-binding protein (TBP) and hypoxanthine phosphoribosyltransferase1 (HPRT1) were used as reference genes. No expression of

  166. 231.

    Narita M, Tomioka R, Miyoshi N, Suita K, et al. · Frontiers in microbiology · 2026 · PMID 42181996

    Antimicrobial peptides (AMPs) are promising agents against multidrug-resistant bacteria. The bovine cathelicidin BMAP-28 is a cationic α-helical AMP with broad-spectrum activity, but its effects on enterococci and determinants of susceptibility remain unclear. Here, we compared the activity of BMAP-28 and four analogs against

  167. 232.

    Santos PA, Maya-Hoyos M, Salazar LM, Cruz CA, et al. · Biomolecules · 2026 · PMID 42194015

    Tuberculosis (TB), caused by

Preprints (not yet peer-reviewed)

7
  1. 233.

    Zielke C, Rad B, Nielsen JE, Li J, Pimcharoen S, Sawant M, Lin JS, Thiam HR, Barron AE. · 2026

    The human cathelicidin host defense peptide LL-37 forms complexes with nucleic acids that can have either beneficial or detrimental health effects. We suggest that these differential impacts are directly connected to dsDNA binding by LL-37 and to complex formation between protomers. Here, we show using phage λ DNA that LL-37 binds non-specifically to dsDNA, condensing it, followed by complex formation between LL-37 peptides. We find that complex formation is concentration-dependent, with low LL-…

  2. 234.

    Atakgayeva G, Porco N, Rudovskaya S, Sarkar M, Tomlinson M, Huynh R, Pucadyil TJ, Botelho RJ, McPhee JB. · 2026

    Antimicrobial peptides are a key component of the innate immune system, serving both as signaling and immunomodulatory molecules and also as direct antimicrobials toward numerous bacterial species. One of the key antimicrobial peptides in humans is LL-37 but the mechanism of bacterial killing remains poorly characterized. Using live-cell imaging, we observe that LL-37 preferentially targets actively dividing E. coli cells. Permeabilization occurs during late-stage division at the bacterial septu…

  3. 235.

    Albin JS, Vithanage DA, Vuong W, Johnson C, Pentelute BL. · 2026

    The human CAMP gene product LL-37 is a prototypical cationic host defense peptide with potent activity against gram-negative bacteria. The development of LL-37 and other membrane-active host defense peptides as antibiotics, however, is limited in part by their activity against mammalian membranes. To better understand the structural features underlying LL-37 functions, we reconceived of LL-37 as a small protein and systematically ablated the sidechain content of entire surfaces while preserving…

  4. 236.

    Fuertes-Chaves C, Gonzalez JE, Suesca E, Guzmán-Sastoque P, Muñoz-Camargo C, Manrique-Moreno M, Carazzone C, Leidy C. · 2026

    <h4>ABSTRACT</h4> Staphylococcus aureus ( S. aureus ) is an opportunistic pathogen that is a global health concern for its ability to cause a wide spectrum of clinical infections. Due to the emergence of resistance to commonly used antibiotics, there has been interest in exploring the use of antimicrobial peptides to treat S. aureus infections. However, changes in the lipid composition of the lipid bilayer membrane can alter the activity of peptides, and S. aureus is able to induce variations in…

  5. 237.

    Dong X, Khuwaja WM, Janjua Z, De Nisco N, Guth C, Pundir P, Rakshit S, Nie L, Green D. · 2026

    <title>Abstract</title> <p>Urinary tract infections (UTIs) are the most common bacterial infections in women. During UTI, the host mounts a rapid immune response to clear the invading pathogen. Mast cells are tissue resident immune cells found in the bladder lamina propria and can serve as first responders to bacterial infections. We investigated the role of the mouse mast cell receptor Mrgprb2 and its human homologue MRGPRX2 in UTI. During acute UTI, Mrgprb2 is activated by the antimicrobial pe…

  6. 238.

    Albin JS, Vithanage DA, Johnson C, Pentelute BL. · 2025

    <h4>Summary</h4> Issues such as potency and stability limit our ability to realize the potential of host defense peptides (HDPs) to serve as new antibiotics. Informed by our prior structure-activity work, we demonstrate that transposition of an N-terminal biphenyl motif from full-length LL-37 onto the previously-described central activity region (residues 18-29) improves activity against gram-negative bacteria by >16-fold. We further improve upon this lead derivative, termed FF-14, using stabili…

  7. 239.

    Ramotar P, Hemshekhar M, Altieri A, van der Does AM, Pascoe C, Mookherjee N. · 2025

    <h4>Background</h4> During airway inflammation, chemokines, oxylipins (bioactive lipids) and cationic host defence peptides (CHDP) are enhanced in the lungs. However, the interplay of these molecules in the process of airway inflammation is not fully resolved. The human cathelicidin CHDP, LL-37, can enhance the expression of chemokines which is turn facilitates influx of leukocytes into the lungs. Moreover, LL-37 can get citrullinated during inflammation and the effect of this post-translational…

Curated sources on file

24
  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.
  20. 20.
  21. 21.
  22. 22.
  23. 23.
  24. 24.

Continue reading